<?xml version="1.0" encoding="utf-8"?>
<add>
	<doc>
		<field name="docid">BR-TU.18615</field>
		<field name="filename">25626_Campos_MariaGabrielaNogueira_D.pdf</field>
		<field name="filetype">PDF</field>
		<field name="text">
UNIVERSIDADE ESTADUAL DE CAMPINAS 

FACULDADE DE ENGENHARIA QUÍMICA 

ÁREA DE CONCENTRAÇÃO / / 
CIÊNCIA E TECNOLOGIA DE MATERIAIS / 

Desenvolvimento e Caracterização de Membranas de Quitosana para 
Recobrimento de Feridas e Liberação Controlada de Fármacos 

Autor Maria Gabriela Nogueira Campos 
Orientador Lucia Helena lnnocentini-Mei 

/ 
/ 

Tese de Doutorado apresentada à Faculdade de Engenharia Química como parte 
dos requisitos exigidos para a obtenção do título de Doutor em Engenharia 1 
Química. 

Campinas - São Paulo 
Agosto 2007 

UN1CAMI' 
BIBLIOTH_~A C~NTR.A.l. 

(fS·\fl. LAlTES 

OEs~:svoLVJMENTo DE CoLEç,\o 



UNIDADE?&amp;amp;,. 
N' CHAMADA: '---,.,"-. "'"1.·:,1 · 

T/UNICAMP 
V. EX. 

TOMBO BC Cl \i -::c;"("') {)"""' ('"') 
PROC 1 h· (&lt;{5 -o.\-
C D ,&lt;. 
PREÇO )1 

1 
IQ 0::-"''---

DATA l 4- jp _ 0 )-
BIB-ID L\ lijl-13&lt;j 

I FICHA CATALOGRÁFICA ELABORADA PELA 
BIBLIOTECA DA ÁREA DE ENGENHARIA E ARQUITETURA - BAE 

UNICAMP 

Cl57d 
Campos, Maria Gabriela Nogueira 

Desenvolvimento e caract,;,rização de membranas de 
quitosana para recobrimentó§.'de feridas e liberação 
controlada de fátmacos. I Maria Gabriela Nogueira 
Campos.--Campinas, SP: [s.n.], 2007. 

01ientador: Lucia Helena Innocentini Mei 
Tese (Doutorado)- Universidade Estadual de 

Campinas, Faculdade de Engenharia Química. 

L Membranas (Tecnologia). 2.Cicatrização de 
feridas. 3. Quitosana. 4. Tecnologia de liberação 
controlada. L Mei, Lucia Helena innocentini. IL 
Universidade Estadual de Campinas. Faculdade de 
Engenharia Química. III. Título. 

Título em Inglês: Development and Characterization of Chitosan 
Membranes for W ound Dressing and Drug Controlled 
Release 

Palavras-chave em Inglês: Membranes, Wound dressing, Chitosan, 
Controlled release 

Área de concentração: Ciência e Tecnologia de Materiais 
Titulação: Doutora em Engenharia Química 
Banca examinadora: Arnaldo Rodrigues dos Santos Junior, Rodrigo 

Lambe1i Oréfice, Fernanda Paula Collares Queiroz, 
Leila Peres 

Data da defesa: 14/08/2007 
Programa de Pós-Graduação: Engenharia Química 



Tese de Doutorado defendida por Maria Gabriela Nogueira Campos e aprovada 
em 14 de agosto de 2007 pela banca examinadora constituída pelos doutores: 

Profa. Ora. Lucia Helena lnnocentini Mei- Orientador I 

Prof. Dr. Rodrigo Lambert Oréfice / 

s Santos Júnior /' 

---:P:::-r-o..,.fa-.-=o,--ra-. ...,F=e-r_n_a_n-:d-a-=P=-a-u-=-la--::C:-o-cll-a-re_s_Q;::-u-e:-iro-z--1 

UNICAMP 
BIBLIOTECA CHHRAL 

CÉSAR LATTES 

DESENVOLVIMENTO DE COLEÇÃO 



Este exemplar corresponde à versão final da Tese de Doutorado em Engenharia 
Qulmi~. I 

dL 
Profa. Dra. Lucia Helena lnnocentini-Mei 



Dedicatória 

Dedico este trabalho a todas as pessoas que amo e que me apoiaram 

durante esta longa jornada: 

• Elza Aparecida Lapadulla Coelho Caldas, Nona, que me incentivou e 

amou durante toda sua vida, mas que infelizmente não está mais aqui 

entre nós; 

• Cleonice Maria Coelho Caldas, Dinha, que esteve presente em todos 

os momentos da minha vida e que até hoje me apóia e incentiva em tudo 

que faço; 

• Maria Carolina Caldas Nogueira, Mariana Caldas Nogueira e Maria 

Luiza Caldas Nogueira, irmãs queridas, companheiras de todos os 

momentos da minha vida; 

• Fernando Ferraz de Campos, marido e amigo, que trabalhou muito 

para que eu chegasse até aqui; 

• Gabriel Nogueira Ferraz de Campos, meu filho amado, fortaleza e 

razão da minha vida; 

E principalmente aos meus pais, Cleuza Maria Coelho Caldas Nogueira e 

Oswaldo Nogueira Junior, pessoas incríveis que através de seu amor 

incondicional, me incentivaram a dar o melhor de mim, sempre! 

11 



Agradecimento 

• Agradeço a orientação e amizade da Profa. Dra. Lucia Helena 

lnnocentini-Mei; 

• Agradeço a acolhida e orientação dos professores Ralph Henry 

Rawls e Neera Satsangi da University of Texas Health Science Center at 

San Antonio; 

• Agradeço o apoio financeiro do Conselho Nacional de Pesquisa -

CNPq e da Coordenação de Aperfeiçoamento de Pessoal de Nível 

Superior; 

• Agradeço a todos que, direta ou indiretamente, contribuíram para a 

realização deste trabalho. 

111 



RESUMO 

O tratamento de feridas de pele (queimaduras, úlceras, feridas cirúrgicas e 

de diabetes) é uma problemática mundial que vem sendo amplamente 

discutida e estudada devido às complicações decorrentes do processo de 

cicatrização, tais como infecções, septicemia e até óbito. 

A pele é a interface do organismo humano com o meio externo e quando 

esta barreira é ferida, a infecção por microorganismos, bem como a perda 

de fluidos e desidratação são conseqüências temíveis. 

Portanto, um recobrimento de ferida deve ser utilizado afim de proteger a 

mesma da invasão de microorganismos e da perda de fluidos, além de 

substituir as funções da pele. 

Os recobrimentos de ferida disponíveis comercialmente são 

principalmente à base de colágeno. Entretanto, devido ao alto custo desta 

matéria-prima, a busca de novos materiais para a confecção de 

recobrimentos de ferida vem sendo constante. 

A quitosana é um biopolímero derivado da quitina, o polissacarídeo mais 

abundante na natureza depois da celulose, encontrada principalmente no 

exoesqueleto de insetos e crustáceos. Além de biocompatível e 

biodegradável, a quitosana apresenta interessantes propriedades 

biológicas, tais como atividades bactericida, fungicida, hemostática, 

antitumoral e imuno-adjuvante. 

O processo de produção de quitosana é econômica e ambientalmente 

viável, pois utiliza subprodutos da indústria pesqueira como matéria-prima. 

Sendo assim, o preço da quitosana purificada é cerca de 20 vezes menor 

que o do colágeno na mesma condição. 

Por estas razões, a quitosana vem sendo amplamente estudada e 

empregada no tratamento de feridas, nas formas de filmes, membranas, 

matrizes porosas, géis e até mesmo soluções. 

i v 



No sentido de melhorar suas propriedades, plastificantes, reticulantes e 

outros polímeros também são utilizados em associação com a quitosana 

afim de se obter um material viável para utilização. 

No presente trabalho, membranas de quitosana para recobrimento de 

feridas foram desenvolvidas, caracterizadas e testadas in vitro e in vivo. O 

efeito do D-sorbitol como plastificante e o do hexametileno diisocianato 

como agente reticulante também foi estudado. Além disso, sistemas de 

liberação controlada de drogas à base de quitosana foram desenvolvidos 

e a liberação de gentamicina e sulfadiazina de prata foi avaliada in vitro. 

O D-sorbitol mostrou-se um bom plastificante para as membranas de 

quitosana, pois melhorou as propriedades mecânicas e aumentou a 

permeabilidade ao vapor de água. Além disso, não apresentou 

citotoxicidades direta e indireta. 

O hexametileno diisocianato foi utilizado como agente reticulante da 

quitosana e foi previamente bloqueado com bissulfito de sódio, afim de 

proteger os grupos reativos e aumentar o rendimento da reação de 

reticulação. 

As membranas reticuladas de quitosana não apresentaram citotoxicidade 

e mostraram-se eficientes sistemas de liberação controlada de 

gentamicina e sulfadiazina de prata. 

v 



ABSTRACT I 
Skin wounds treatment (burns, ulcers, surgical and diabetes wounds) is a 

world-wide problem that has been widely argued and studied due to the 

healing process complications, such as infections, septicemia and death. 

The skin is the interface of the human organism with the externai 

environment and when this barrier is wounded, microorganism infections, 

as well as the loss of fluids and dehydration are possible consequences. 

Therefore, a wound dressing must be used to protect the wound from 

microorganisms' invasion and loss of fluids, besides substituting functions 

of the los! skin. Commercially available wound dressings are mainly based 

on collagen. However, because of the high cost of this raw material, the 

search for new materiais for wound dressings has been continuous. 

Chitosan is a biopolymer derived from chitin, the most abundant 

polysaccharide found in nature after cellulose, found mainly in insects and 

crustaceans exoskeletons. Beyond biocompatible and biodegradable, 

chitosan also presents interesting biological properties, such as 

bactericida!, fungicida!, hemostatic, immune-adjuvant and anti-tumor 

activities. The process of chitosan production is economic and 

environmentally viable; since it uses fishing industry by-products as raw 

material. Thus, pure chitosan price is about 20 times cheaper than 

collagen one. For these reasons, chitosan has been widely studied and 

employed in the treatment of wounds like film, membrane, porous matrix, 

gel and solution. Moreover, plasticizers cross linkers and other polymers 

are also used in association with chitosan to improve the obtained material 

properties. In this present work, chitosan membranes for wound dressing 

had been developed and characterized. The use of D-sorbitol as plasticizer 

and hexamethylene diisocyanate as cross-linker also was investigated. 

Moreover, chitosan based drug release systems based was developed and 

the releases of gentamicin and silver sulfadiazine were in vitro evaluated. 

D-sorbitol revealed a good plasticizer for chitosan membranes: it improved 

mechanical properties and increased water vapor permeability. Moreover, 

it did not show direct and indirect cytotoxicity. 

VI 



Hexamethylene diisocyanate was previously blocked with sodium bisulfite 

to protect reactive groups and to increase chitosan cross linking reaction 

yield. Cross linked membranes had not shown cytotoxicity and had 

revealed to be efficient systems for controlled release of gentamicin and 

silver sulfadiazine. 

V li 



SUMÁRIO 

1. APRESENTAÇÃ0 ..........•.................••............................................................... 2 
2. INTRODUÇÃO .....................................•..•........................•................................ 3 

2.1 Problemática .....................................•.....•........................................... 3 

2.2 A Quitosana ...•..............................••..•..............•...................•............... 6 

2.3 O Agente Reticulador ...............•.••...•.............................•.•.................. 9 

2.4 Os Fármacos ................•................•...•.................................................. 12 

3. REVISÃO BIBLIOGRÁFICA .......................................•.........•...................... 14 
4. OBJETIVOS .......•...•.......•.....................................................•......•.................... 19 
5. TRABALHOS CIENTÍFICOS .......•...•..•........................•......................•......... 21 

4.1 Effects of Neutralization Process on Preparation and Characterization 

of Chitosan Membranes for Wound Dressing ...•.................•.•.....•...•....... 21 

4.2 Antibacterial Activity of Chitosan Solutions for Wound 

Dressing .............................................................................•......•................ 31 

4.3 In vitro Cytotoxicty Evaluation of Chitosan Membranes for Wound 

Dressing ..........................................................•................. 38 

4.4 In vitro Cytotoxicity of Chitosan Membranes against Vero 

cells .................................................................................. 44 

4.5 Crystallinity versus Water Vapor Permeability of Chitosan 

Membranes for Wound Dressing ..•............................•........ 60 

4.6 In Vitro Gentamicin Sustained and Controlled Release from Chitosan 

Cross Linked Films ............................................................... 70 

4.7 In vitro Silver sulfadiazine Controlled Release from Chitosan cross 

linked Films ........................................................................ 85 

4.8 In Vitro Wound Healing Responses to Drug Loaded Cross Linked 

Chitosan Films.............................................................. .... 96 

6. CONCLUSÕES ............................................................................................... 108 
7. SUGESTÕES PARA TRABALHOS FUTUROS ........................................ 111 
8. REFERÊNCIAS .......•...................•...•...•..•.............................................•........ 112 
9. APÊNDICES ................................................................................................... 117 
9.1 TESTEINVIV0 ........................................................................................... 117 
9.2 CURVAS DE DSC ........................................................................................ 119 

1 



1. APRESENTAÇÃO 

Esta tese de Doutorado é um dos requisitos exigidos para a obtenção do 

Título de Doutor em Engenharia Química e será apresentada com os 

capítulos no formato de trabalhos científicos. 

A primeira parte do conteúdo apresentado (Desenvolvimento e 

Caracterização de Membranas de Quitosana para Recobrimento de 

Feridas) foi realizada na Universidade Estadual de Campinas, na 

Faculdade de Engenharia Química, Departamento de Tecnologia de 

Polímeros, com apoio de outras unidades, tais como a Faculdade de 

Engenharia de Alimentos e os Institutos de Biologia e Química. 

A segunda parte, Desenvolvimento e Caracterização de Membranas de 

Quitosana Reticulada para Liberação Controlada de Fármacos, foi 

realizada na University of Texas Health Science Center at San Antonio, na 

Divisão de Biomateriais da Escola de Odontologia, apoiada pelo Programa 

de Doutorado com Estágio no Exterior- PDEE/CAPES, sob orientação do 

Prof. Dr. Ralph Rawls e da Prata. Ora. Neera Satsangi. 

2 



2. INTRODUÇÃO I 
2.1 Problemática 

A existência de uma variedade de tipos de feridas com diversos modos e 

fases de cicatrização contribuiu para a evolução dos recobrimentos 

atualmente existentes. 

Até aos anos 60 (século XX), os recobrimentos de ferida eram 

considerados produtos passivos, com mínima influência no processo de 

cicatrização. Porém, a pesquisa pioneira de Winter (1 960) iniciou uma 

nova fase, onde foi considerado o envolvimento ativo do recobrimento com 

a ferida, com a finalidade de estabelecer e manter um ambiente ótimo 

para a cicatrização da mesma. Assim, foi dado início a um novo conceito 

de recobrimento, que resultou na evolução dos materiais passivos para os 

funcionalmente ativos, onde a interação do recobrimento com a ferida a 

ser coberta e cicatrizada foi enfatizada (PURNA e BABU, 2000). 

O recobrimento de feridas continua sendo uma área de interesse de 

pesquisadores do mundo todo devido a sua grande importância no 

tratamento de traumas, queimaduras, ferida de diabetes, úlceras de pele e 

outros danos teciduais, tais como as feridas pós-cirúrgicas. 

Nos Estados Unidos, cerca de 70.000 pessoas são hospitalizadas a cada 

ano, com ferimentos graves causados por trauma térmico (BLACK, 1 996). 

No Brasil, não se têm dados estatísticos precisos, mas estima-se que 

quase um milhão de acidentes com queimaduras ocorre por ano, e destes, 

aproximadamente 200 mil são notificados pelos hospitais e cerca de 1 O mil 

causam falecimento das vítimas (Cidade Sustentável, 2004). De acordo 

com os dados do Ministério da Saúde, o Sistema Único de Saúde (SUS) 

atendeu 27.906 pacientes queimados em 1 998 e 27.694 em 1 999. No ano 

seguinte, o governo brasileiro gastou 55 milhões de reais no tratamento de 

queimaduras (Portal Saúde.Gov, 2005). 

O diabetes atinge cerca de dez milhões de pessoas no Brasil, e a 

incidência desta doença só tende a aumentar devido aos fatores de risco 

da população, tais como: sedentarismo, estresse, tabagismo e obesidade 

3 



(LAVA, 2005). Dentre os possíveis distúrbios, o diabetes pode causar 

úlceras no pé (feridas) e infecções que podem evoluir para o caso extremo 

de amputação. 

No caso das úlceras de pele, estas podem ser causadas por diversos 

fatores: varizes, hipertensão arterial, anemia falciforme, diabetes, isquemia 

e infecções. Devido à grande incidência de anemia e infecções nas 

populações mais carentes, este tipo de ferida apresenta grande incidência 

no Brasil e nos demais países subdesenvolvidos. 

No âmbito da saúde mundial, as feridas pós-cirúrgicas apresentam grande 

preocupação pelo fato de serem consideradas alvos fáceis para a 

instalação de infecção, principalmente da temida infecção hospitalar. Nos 

Estados Unidos, estima-se que das 23 milhões de cirurgias realizadas por 

ano, 920 mil desenvolvem infecções da ferida operatória, o que está 

associado ao aumento do tempo de internação, das taxas de letalidade e 

dos gastos hospitalares (KLUYTMANS, 1997). No Brasil, de acordo com o 

estudo prospectivo efetuado em um hospital universitário entre 1995 e 

1999 por FERRAZ et ai. (2001) aproximadamente 1 O% das feridas 

cirúrgicas apresentam infecção. 

O tratamento da ferida infectada exige, além de um maior tempo de 

internação do paciente, o uso de antibióticos de terceira geração que, no 

Brasil, custam em média R$ 600/dose (lnventaBrasiiNet, 2001 ). 

Neste contexto, o desenvolvimento de um recobrimento de feridas 

eficiente tem um papel fundamental no tratamento das lesões de pele, na 

prevenção de infecções, bem como na melhoria da qualidade de vida dos 

pacientes e na redução dos gastos, especialmente do governo, com 

internações hospitalares e tratamentos. 

Para tanto, um recobrimento de ferida ideal deve substituir as funções da 

pele perdida: proteger a ferida da perda de fluidos e proteínas; prevenir a 

invasão de bactérias; dissipar o estresse mecânico externo; e, bem como 

melhorar e estimular a cicatrização da ferida. Além disso, o material deve 

4 



ser biocompatível para evitar rejeição e apresentar um custo acessível, 

para que sua utilização seja economicamente viável. 

5 



2.2 A Quitosana 

A quitosana é um polímero derivado da quitina, o segundo polissacarídeo 

mais abundante na natureza, encontrado principalmente no exoesqueleto 

de insetos e nas carapaças de crustáceos. Pode ser encontrada na 

parede celular de algumas espécies de fungos, porém sua maior fonte de 

obtenção é através da desacetilação da quitina. No Brasil, foi criada, em 

1997, uma empresa de base tecnológica, incubada no Parque de 

Desenvolvimento Tecnológico da Universidade Federal do Ceará e 

especializada na extração de quitina e produção de quitosana, obtidas a 

partir de carapaças de camarão, lagosta e caranguejo extraídos da costa 

brasileira (Polymar, 2004). O baixo custo de produção, a abundância de 

matéria-prima (fonte renovável) e o aproveitamento dos subprodutos da 

pesca de crustáceos tornam o processo de produção de quitosana 

ecologicamente interessante e economicamente viável. 

Além de ser biocompatível, a quitosana é biodegradável e apresenta baixa 

toxicidade. Também apresenta atividades antimicrobiana, antitumoral e 

imuno-adjuvante (KURITA, 1998). Ela é capaz de acelerar o processo de 

cicatrização, através da ativação de macrófagos e fibroblastos, 

aumentando a síntese de ácido hialurônico e sua deposição no tecido 

conjuntivo regenerativo, bem como influenciando no depósito de colágeno 

nas matrizes extra-celulares durante a reconstrução do tecido invalidado 

(SYNOWIECKI e AL-KHATEEB, 2003). 

Por todas estas razões, a quitosana foi escolhida como material de estudo 

do presente projeto, que envolve a caracterização deste material, bem 

como o desenvolvimento de um recobrimento de ferida baseado no 

mesmo. 

Nas Figuras (1) e (2) têm-se as fórmulas estruturais da quitina e da 

quitosana, apresentando como principal diferença entre elas, a presença 

de grupos acetil em maior número na cadeia de quitina. 

6 



Figura 1: Estrutura da quitina. 

Figura 2: Estrutura da quitosana. 

O grau de desacetilação, ou seja, a quantidade de grupos acetil removidos 

na desacetilação da quitina, é um importante parâmetro de classificação 

da quitosana, assim como o peso molecular. 

Estes parâmetros têm influência direta nas atividades antibacteriana, 

antitumoral e imuno-adjuvante, bem nas propriedades mecânicas da 

quitosana. 

MAEDA e KIMURA (2004) avaliaram o efeito do peso molecular da 

quitosana na sua atividade antitumoral e observaram que as moléculas de 

menor peso molecular promoveram uma diminuição no crescimento dos 

tumores. 

KURITA (1998) avaliou o efeito do peso molecular na atividade 

antibacteriana da quitosana contra algumas espécies de Streptococcus e 

constatou que quanto maior o peso molecular, maior a repressão do 

crescimento desta bactéria. 

WELING e colaboradores (2005) estudaram o efeito do grau de 

desacetilação da quitosana na cristalinidade, tração e compatibilidade com 

células Schawnn e concluíram que, para um mesmo peso molecular, o 

7 



aumento do grau de desacetilação promove um aumento na cristalinidade, 

tração e afinidade com células Schawnn. 

A quitosana é solúvel em meio ácido e insolúvel em meio alcalino e na 

água. Em pH fisiológico, apresenta carga positiva, o que promove a 

bioadesão da mesma. Devido à protonação em meio ácido dos grupos 

amino presentes em sua cadeia carbônica, além das hidroxilas 

provenientes dos grupos álcool, a quitosana apresenta caráter 

higroscópico e é capaz de formar gel, podendo absorver até 400% da sua 

massa inicial em meio aquoso. 

Dessa forma, o desenvolvimento de sistemas de liberação controlada de 

fármacos por difusão à base de quitosana seria inviável sem a utilização 

de um agente reticulador, que manteria as moléculas interligadas e 

diminuiria o grau de inchamento da mesma. 

8 



2.3 O Agente Reticulador 

A reticulação entre cadeias poliméricas é obtida através da reação 

química entre os grupos funcionais das mesma. Ela pode ocorrer através 

da adição de um iniciador, quando a própria cadeia polimérica apresenta 

grupos funcionais reativos entre si; ou pela a adição de moléculas reativas 

e multifuncionais (reticulantes ou agentes reticuladores). Quando 

introduzidos no meio polimérico, os agentes reticulantes reagem em suas 

extremidades funcionais com determinados grupos funcionais presentes 

nas cadeias poliméricas, fazendo a ligação entre as mesmas. Dessa 

forma, uma rede polimérica é formada, promovendo uma maior interação 

entre as moléculas e significativas mudanças nas propriedades físicas e 

químicas do polímero inicial. 

No caso da quitosana, as reações de reticulação podem ocorrer em dois 

grupos funcionais da molécula, isto é, nos grupos amino e nas hidroxilas. 

Além disso, modificações químicas também podem ser feitas a partir do 

grupo N-acetil, de acordo com o grau de desacetilação da quitosana. 

Diferentes propriedades são obtidas de acordo com o grupo funcional 

envolvido, bem como com o agente reticulador utilizado e com o grau de 

reticulação da reação. 

A epicloridrina é um exemplo de agente reticulador que se interliga às 

hidroxilas da quitosana. Já o glutaraldeído, um dos reticulantes mais 

usados, é responsável pela reação entre os grupos amino da quitosana e 

os grupos aldeídos do glutaraldeído. Entretanto, esta reação, apesar de 

melhorar as propriedades químicas do material, promove uma diminuição 

das propriedades mecânicas, deixando o material mais quebradiço. 

Dessa forma, o principal desafio deste projeto foi encontrar um agente 

reticulante capaz de interligar as cadeias poliméricas sem interferir 

negativamente nas propriedades do polímero. Além disso, o material 

resultante da reticulação deveria manter ou aumentar a biocompatibilidade 

do polímero inicial. 

9 



Os diisocianatos (Figura 3) são moléculas bifuncionais e de elevada 

reatividade, amplamente utilizadas como agentes reticulantes, 

principalmente na produção de poliuretanos, incluindo os utilizados na 

área médica. Na Figura 3, o radical R pode ser um grupo alifático ou 

aromático e tem uma forte influência nas propriedades do material 

resultante da reação. Dessa forma, é possível controlar as características 

do produto final, variando-se o radical R do diisocianato utilizado. 

I Ü=C=N-R-N=C=O I 
Figura 3. Fórmula molecular geral dos diisocianatos. 

Neste presente trabalho, o 1 ,6-Diisocianato hexano ou Hexametileno 

diisocianato (Figura 4) foi escolhido por ser uma molécula linear, flexível, 

devido à presença dos grupos -CH 2 , e simétrica, com os dois grupos 

cianatos (- N =C= O) de igual reatividade. Além disso, a escolha de um 

radical alifático insaturado aumenta a estabilidade do produto final, 

evitando o amarelamento do mesmo com o tempo de estocagem. 

Figura 4. Fórmula molecular do hexametileno diisocianato. 

O hexametileno diisocianato, bem como a maioria dos isocianatos, é 

insolúvel em água, além de reagir com a mesma. Dessa forma, é 

necessária uma reação prévia de proteção dos grupos reativos (cianatos) 

para evitar a reação com a água e, ao mesmo tempo, promover a 

dissolução do mesmo em meio aquoso, uma vez que a reação com 

quitosana ocorreria em solução aquosa de ácido acético. 

Os bissulfitos são exemplos de sais utilizados nas reações de proteção 

dos diisocianatos. O bissulfito de sódio (Na2S20 5), um sal bastante reativo 

e solúvel em água, foi utilizado na reação de bloqueio dos grupos cianatos 

do hexametileno diisocianato, obtendo-se o hexametileno -1 ,6 - di -

(aminocarboxisulfonato) como produto principal da reação (Figura 5) 

(WELSH et ai., 2002). 

lO 



Figura 5. Fórmula estrutural do hexametileno -1 ,6 -di -

(aminocarboxisulfonato). 

O hexametileno - 1,6 - di - (aminocarboxisulfonato) é solúvel em água e 

além disso, estável em soluções aquosas ácidas. Dessa forma, a reação 

de reticulação da quitosana ocorre a partir da formação de ligações uréia, 

já que a taxa de reação do hexametileno 1 ,6 -di 

(aminocarboxisulfonato) com o grupo amina em meio ácido é muito maior 

do que a taxa de reação competitiva com os grupos álcool ou água. 

11 



2.4 Os Fármacos 

O tratamento de feridas de pele, na maioria dos casos, exige a aplicação 

de um medicamento anti-microbiano para evitar ou combater a infecção. 

Devido à grande exposição da pele ao meio externo, o contato com os 

microorganismos é constante e inevitável. Os microorganismos mais 

comumente encontrados em feridas de pele são o Staphylococcus aureus 

e a Pseudomonas aeruginosa, espécies gram positivo e gram negativo, 

respectivamente. Dessa forma, seria interessante encontrar um agente 

antimicrobiano capaz de matar ou inibir o crescimento de pelo menos 

essas duas espécies de bactéria. 

Dentre os agentes antimicrobianos disponíveis, a gentamicina é um 

antibiótico pertencente à família dos aminoglicosídeos, isolada em 1963, a 

partir do fungo de solo Micromonospora purpura, por Weinstein e seus 

colaboradores. Foi introduzida nos Estados Unidos da América em 1969 e, 

desde então, tem sido utilizada muito no tratamento de diversas infecções, 

devido ao seu baixo custo e ampla faixa de atividade antibacteriana. 

A gentamicina tem dois aminoglicoses ligados a um núcleo hexose através 

de uma ligação glicosídea e tem sua fórmula estrutural apresentada na 

Figura 6: 

Figura 6. Fórmula estrutural do sulfato de gentamicina. 

O sulfato de gentamicina é altamente solúvel em água; moderadamente 

solúvel em etano!, metano! e acetona e praticamente insolúvel em 

benzeno e hidrocarbonetos halogenados. Uma solução a 4% em água 

apresenta pH entre 3,5 e 5,5. 

12 



As concentrações mínimas (CMI) de gentamicina para a inibição do 

crescimento de Pseudomonas aeruginosa e Escherichia co/i variam de 

0,06 a 8 11g/ml e de O, 12 a 1 ,O 11g/ml para o Staphylococcus aureus. 

(SKUNDRIC et ai., 2002) 

Outro agente antibacteriano testado no presente trabalho foi a sulfadiazina 

de prata. A sulfadiazina (Figura ?a) é um antibiótico que elimina as 

bactérias através da inibição da produção de ácido fólico no interior de 

suas células. Ela é comumente usada em associação com prata (Figura 

7b) no tratamento de feridas de pele, sendo um tratamento padrão para 

queimaduras, úlceras e feridas infectadas devido ao seu amplo espectro 

de atividade bactericida contra as espécies gram positivo e negativo. 

(a) (b) 

Figura 7. Fórmula estrutural da (a) sulfadiazina e (b) da sulfadiazina de 

prata. 

As concentrações mínimas de inibição da sulfadiazina de prata são de 

32,0 11g/ml para a Escherichia co/i, 44,8 11g/ml para a Pseudomonas 

aeruginosa e 57,6 jlg/ml para o Staphylococcus aureus. Além disso, as 

concentrações mínimas para efeito bactericida (CMB) são de 40,2 jlg/ml e 

51,2 119/ml para Escherichia co/i e Pseudomonas aeruginosa, 

respectivamente. Para a Staphylococcus aureus a CMB é igual à CMI. 

(SHANMUGASUNDARAM et ai., 2005) 

13 



3. REVISÃO BIBLIOGRÁFICA 

Recobrimento de feridas ou pele artificial é atualmente uma interessante 

área de pesquisa devido à sua grande importância no tratamento de 

traumas, queimaduras, feridas de diabete, úlceras de pele e outros danos 

cutâneos, tais como feridas cirúrgicas. (DENKBAS et ai., 2004) 

As principais funções de um recobrimento de ferida são: 

• Substituir a função da pele perdida; 

• Proteger a ferida da perda de fluidos e proteínas; 

• Prevenir a invasão de bactérias; 

• Dissipar o stress mecânico; 

• Melhorar e estimular a cicatrização; 

• Promover adequadas trocas gasosas e de calor com o ambiente 

externo; 

• Ser biocompatível e não-tóxico. 

Pesquisas desenvolvidas na área biomédica geraram várias opções 

comerciais de recobrimentos de ferida , tais como: Bioprocess®, Opsite® 

e Biobrane®, produzidos a partir de colágeno, ácido hialurônico e outros 

biomateriais. Entretanto, tais produtos apresentam alto custo, o que 

dificulta a aplicação e comercialização dos mesmos, principalmente nos 

países emergentes. 

A Tabela 1 descreve outros exemplos de recobrimentos utilizados no 

tratamento de feridas, entretanto, estes também apresentam alto custo, 

além de outros inconvenientes. 

Neste contexto, a busca por produtos econômica e funcionalmente viáveis 

ainda é uma realidade nesta área de pesquisa. 

A quitosana é um biomaterial que vêm sendo extensivamente estudado 

devido às suas interessantes propriedades. Além de biodegradável e 

biocompatível, a quitosana apresenta atividades antibacteriana, fungicida, 

14 



hemostática, imuno-adjuvante e antitumoral. (KURITA, 1998) 

A quitosana também apresenta vantagens econômico-ambientais, uma 

vez que a mesma é produzida a partir da desacetilação da quitina, 

extraída principalmente dos subprodutos da indústria pesqueira e cuja 

produção biológica anual é de cerca de 1 bilhão de toneladas. Além disso, 

o preço da quitosana purificada é cerca de 20 vezes menor que o do 

colágeno na mesma condição, o que a torna ainda mais atrativa em um 

país em desenvolvimento como o Brasil. 

Tabela 1 -Alternativas ao tratamento de feridas. 

TIPO DESCRIÇÃO INCONVENIENTES 

Biobrane: borracha de siliconei 
nylonlpeptideos derivados de Os recobrimentos 

Sintéticos 
colágeno de porco; poliméricos somente são 

usados em feridas pequenas, 
e 

Epigard: poliuretano reticulado/ capazes de cicatrizar 
Semi-

filme de poliuretano poroso; pelo movimento das células 
sintéticos epiteliais através da ferida, 

Outros: poli-tetra-flúor-etileno a partir das bordas; 
ou poliuretano/pectina ou metil Alto custo. 

celulose. 

Compostos 
Yannas: camada externa de Substituto temporário; 

de 
si li cone e sub camada esponjosa Necessita de enxerto 

Colágeno 
de colágeno reticulado com posterior; 

glutaraldeido. Alto custo do colágeno. 

Células de derme e Consiste em uma matriz de 21 dias para o crescimento 
epiderme células epidermais e fibroblastos da cultura de células 

semeados. epidermais; Alto custo. 

Diversos trabalhos envolvendo o uso de quitosana na preparação de 

recobrimento de feridas já foram publicados. Dentre eles, o estudo de Ml e 

seus colaboradores (2001) relatou o desenvolvimento de uma membrana 

assimétrica de quitosana composta por duas camadas, sendo uma densa 

e a outra porosa, com o intuito de melhor controlar as trocas gasosas e de 

fluído com o meio externo. 

SILVA e colaboradores (2004) também prepararam membranas de 

quitosana, porém utilizaram o glutaraldeído como agente reticulador. Além 

15 



da aplicabilidade na área biomédica, os autores também avaliaram as 

propriedades mecânicas do material obtido. 

LIN-GIBSON (2003) e WELSH et ai. (2002) investigaram a cinética da 

reação de reticulação de quitosana com hexametileno diisocianato nas 

fases líquida e sólida, com a finalidade de utilizar o produto obtido para 

recobrir feridas. 

Um trabalho também interessante foi desenvolvido por OSKAYANAK e 

colaboradores (2005), os quais prepararam membranas para 

recobrimentos de feridas à base de poliuretano, obtido a partir de fontes 

alternativas ao petróleo. 

Além destes, diversos outros trabalhos sobre blendas poliméricas, 

também utilizadas na preparação de membranas para recobrimento de 

feridas, vêm sendo publicados. Dentre os polímeros naturais, o colágeno, 

o alginato e o ácido hialurônico são os principais exemplos de materiais 

misturados com quitosana. 

Além disso, polímeros sintéticos também estão sendo usados na 

preparação de substitutos de pele. MANGALA e colaboradores (2003) 

desenvolveram uma membrana para recobrimento de queimaduras à base 

de quitosana e poli (álcool vinílico). 

Os recobrimentos de feridas também podem ser utilizados como suporte 

para liberação controlada de drogas, uma vez que as feridas são grandes 

focos para a instalação de infecção por microorganismos. Staphylococcus 

aureus, Pseudomonas aeruginosa e Escherichia co/i são os potenciais 

patógenos encontrados em ferida de pele. 

As drogas mais comuns associadas ao tratamento de feridas de pele são 

os antibióticos. DENKBAS e colaboradores (2004) desenvolveram 

esponjas de quitosana impregnadas de norfaloxina para recobrimento de 

ferida e, ao mesmo tempo, liberação controlada do antibiótico. LOKE e 

colaboradores (1999) desenvolveram um recobrimento de ferida à base de 

quitosana capaz de liberar clorexidina. CRUZ e colaboradores (2004) 

estudaram a liberação controlada de oxitetraciclina em matrizes de 

16 



quitosana e quitosana/alginato em diferentes pHs, porém o sistema de 

liberação não foi aplicado como recobrimento de ferida. 

A gentamicina (Figura 6) é um antibiótico pertencente à família dos 

aminoglicosídeos, introduzido nos Estados Unidos da América em 1969 e, 

desde então, é mundialmente utilizada no tratamento de diversas 

infecções, devido ao seu baixo custo e ampla faixa de atividade 

antibacteriana. ZHANG e ZAHANG (2002) desenvolveram um suporte à 

base de quitosana e cálcio, impregnado com gentamicina, para ser usado 

no tratamento de osteomielite. Além deste, diversos outros trabalhos 

foram encontrados na literatura abordando a liberação controlada de 

gentamicina para o tratamento de infecções ósseas (VIRTO et ai., 2002; 

NARAHARISETTI et ai., 2005 e ZHANG et ai., 1994). Entretanto, nenhum 

trabalho abordando a liberação controlada de gentamicina a partir de 

recobrimentos de feridas de pele foi encontrado, mesmo sendo o 

tratamento de feridas com gentamicina um procedimento muito comum. 

Outro medicamento bastante utilizado como agente antimicrobiano, 

principalmente no tratamento de queimaduras, é a sulfadiazina de prata 

(Figura ?b). Devido a sua ampla faixa de atividade antibacteriana, a 

sulfadiazina de prata tem sido um dos fármacos mais estudados na área 

de recobrimentos de feridas e liberação controlada. Em 2003, Ml e 

colaboradores apresentaram um novo tipo de recobrimento de ferida 

carregado com sulfadiazina, enquanto que YU et ai. (2005) investigou a 

atividade antibacteriana de esponjas de quitosana e alginato incorporadas 

com sulfadiazina de prata. 

Alguns trabalhos relatam o uso de antibióticos no tratamento de feridas e 

os efeitos deletérios que eles podem causar ao crescimento celular. CHO 

LEE e colaboradores (2002) mostraram o efeito citotóxico da sulfadiazina 

de prata, bem como o atraso no processo de epitelização, em um modelo 

de queimadura de segundo grau em animais. 

Devido à grande complexidade que envolve o processo de cicatrização de 

feridas, diversos fatores devem ser considerados na elaboração de um 

17 



recobrimento para as mesmas. Os recobrimentos cientificamente 

propostos muitas vezes atendem somente a algumas das exigências e, 

portanto, a busca por um recobrimento de feridas ideal ainda é contínua. 

Sendo assim, este trabalho teve como objetivo principal contribuir para o 

desenvolvimento de um recobrimento de ferida que fosse econômica, 

científica e funcionalmente viável. 

18 



4. OBJETIVOS 

O objetivo geral deste trabalho foi o desenvolvimento e a caracterização 

de membranas à base de quitosana para recobrimento de feridas 

liberação controlada de fármacos à base de quitosana. 

Os objetivos específicos foram: 

• Aprimoramento da técnica de preparação de membranas de 

quitosana, através da definição de parâmetros, tais como: 

temperatura e tempo de secagem; 

• Avaliação do efeito da neutralização na preparação e nas 

características finais das membranas de quitosana; 

• Avaliação do efeito da adição de plastificante; 

• Avaliação da citotoxicidade das membranas de quitosana; 

• Avaliação da atividade antibacteriana das soluções de quitosana; 

• Caracterização morfológica das membranas por Microscopia 

Eletrônica de Varredura e Difractometria de Raios- X; 

• Caracterização das membranas por Calorimetria Diferencial 

Exploratória, afim de se obter os valores das temperaturas de fusão 

e transição vítrea e entalpia de fusão; 

• Avaliação da permeabilidade ao vapor de água das membranas de 

quitosana, bem como parâmetros de solubilidade e umidade; 

Os objetivos do estágio de doutorado no exterior, realizado na divisão 

de biomateriais da Universidade do Texas em San Antonio - EUA, 

foram: 

• Estudo da aplicação de um agente reticulante alternativo para a 

reticulação da quitosana; 

• Desenvolvimento das técnicas de reticulação da quitosana e de 

preparação de membranas reticuladas; 

19 



• Avaliação dos efeitos da reticulação da quitosana, bem como 

caracterização das membranas reticuladas; 

• Avaliação do uso das membranas de quitosana reticuladas como 

sistema de liberação controlada de fármacos; 

• Avaliação da liberação controlada dos fármacos estudados; 

• Caracterização in vitro das membranas reticuladas de quitosana 

como sistemas de liberação controlada de fármacos. 

20 



5. TRABALHOS CIENTÍFICOS 

4.1 Effects of Neutralization Process on Preparation and 

Characterization of Chitosan Membranes for Wound Dressing 

Publicado na Revista Macromolecular Symposia, Vol. 229, p. 253-257, 

2005 DOI: 10.1 002/masy.200551131. 

Efeitos do processo de neutralização na preparação e caracterização 

de membranas de quitosana para recobrimento de feridas 

Maria Gabriela Nogueira Campos*1 , Carlos Raimundo Ferreira Grosso2 , 

Galo Cárdenas3 , Lucia Helena lnocentinni Mei 1 

1 
Laboratório de Biomateriais, Faculdade de Engenharia Química da Universidade 

Estadual de Campinas, Brasil; E-mail: gabi@leq.unicamp.br 

2 Departamento de Alimentos e Nutrição, Faculdade de Engenharia de Alimentos da 

Universidade Estadual de Campinas, Brasil 

3 Departamento de Polímeros, Faculdade de Ciências Químicas da Universidade de 

Concepción, Chile 

Resumo: Os efeitos da neutralização na preparação e caracterização de 

membranas de quitosana foram avaliados por Calorimetria Diferencial 

Exploratória e por Microscopia Eletrônica de Varredura. A solubilidade em 

água e a umidade das membranas de quitosana também foram 

estudadas. A absorção de água em diferentes pHs foi avaliada e as 

propriedades mecânicas, tais como tração e deformação na ruptura foram 

medidas. A neutralização provocou um aumento na temperatura de 

transição vítrea das membranas de quitosana, além de uma diminuição na 

solubilidade em água, umidade e absorção de água. Um aumento nas 

propriedades mecânicas também foi observado após a neutralização. 

Palavras-chave: biomateriais; quitosana; membranas; recobrimento de 

feridas; processo de neutralização. 

21 

---··--·--· -·· ----·--····-·\ 
UNlCAMf' , 

BIBLIOTECA CENTV.l. 

CÉSAR LATTES 

DESENVOLVIMENTO DE COLEÇAO 



Effects of neutralization process on preparation and characterization 

of chitosan membranes for wound dressing 

Maria Gabriela Nogueira Campos*\ Carlos Raimundo Ferreira Grosso2 , 

Galo Cárdenas3, Lucia Helena lnocentinni Mei 1 

1 Laboratory of Biomaterials, Faculty of Chemical Engineering, State 

University of Campinas, Brazil; E-mail: gabi@feq.unicamp.br 

2 Department of Foods and Nutrition, Faculty of Food Engineering, State 

University of Campinas, Brazil 

3 Department of Polymers, Faculty of Chemical Science, University of 

Concepción, Chile 

Summary: Neutralization process effects on preparation and 

characterization of chitosan membranes were evaluated by Differencial 

Scanning Calorimetry and Scanning Electron Microscopy. Water solubility 

and humidity of chitosan membranes were also studied. Swelling behavoir 

in different pH media was evaluated and mechanical properties such as 

tensile strength and elongation at break were measured. Neutralization 

process increased glass transition temperature of chitosan membranes 

and decreased their water solubility, humidity and water sorption. An 

improvement in mechanical properties of chitosan membranes was also 

observed after neutralization process. 

Keywords: biomaterials; chitosan; membranes; wound dressing; 

neutralization process. 

lntroduction 

Wound dressing is an area of current research interest due to its great 

importance in treatment of traumas, burns, diabetes wound, skin ulcers 

and other skin damages, such as surgical wounds111. 

An ideal wound dressing should replace the function of lost skin, protect 

wounds from fluid and protein losses, preveni bacterial invasion, and 

dissipate mechanical stress (externai), and finally, improve and stimulate 

22 



wound healing12l. Moreover, it should promete adequate gaseous and heat 

exchange with environment and be biocompatible and non-antigenic to 

avoid body rejection. 13J 

Developments in the area of biomaterials offer several commercial wound 

dressings like Bioprocess®, Opsite® and Biobrane 11®, based on collagen, 

hyaluronic acid and other biomaterials. However, they do not have a very 

accessible cost. 

Chitosan is a biopolymer obtained by the deacetylation of chitin, which is 

the second more abundant polysaccharide found in nature. Chitin is mainly 

found in externai skeleton of insects and in shells of crustaceans. Thus, 

chitosan production process is ecologically interesting and economically 

viable dueto the use of seafood industry by-products.14l 

Moreover, chitosan exhibits various interesting biological activities, which 

made this polysaccharide increasingly important. Typical activities include 

antitumoral, immunoadjuvant, antibacterial and hemostatic activities. 15l 

Chitosan is metabolized by certain human enzymes, especially lysozyme, 

and is considered biodegradable.16l lt also can accelerate wound healing.17l 

In addition, due to its positive charges at physiological pH, chitosan is 

bioadesive, which increases retention at lhe site of application.l8l For ali 

those reasons, chitosan is one of lhe most important biomaterials for 

wound management in lhe recent years. 

In this present study, chitosan membranes for wound dressing were 

prepared by a solvent evaporation technique and then neutralized, in order 

to evaluate the effects of neutralization process on their preparation and 

characterization. 

Experimental 

Materiais 

High molecular weight chitosan (Mw - 1 00,000), more than 75% 

deacetylated, was purchased from Aldrich Chemical Company (USA). 

Glacial acetic acid was purchased from Synth (Brazil). Chitosan was 

dissolved in an acetic acid aqueous solution (1.0 % w/w) and then was 

23 



filtered to remove any undissolved impurities. 

Preparation of the membranes 

Chitosan membranes were prepared by a solvent evaporation technique 

by using aqueous acetic acid (1.0 % w/w) as solvent. Chitosan solution 

was prepared by dissolving 1.5g of chitosan in 100 ml of solvent. After 

complete dissolution, it was filtered and cast on Petri plates. Following this, 

chitosan membrane (C1) was obtained by solution evaporation in an oven 

at 40"C. Neutralized chitosan membrane (C2) was prepared by immersion 

of C1 into NaOH (2% w/w)- Na2C03 (0.05% w/w) aqueous solution for 1 

hour. After the immersion, it was repeatedly washed with distillated water 

and dried at 40 o C. 

Modulated Differential Scanning Calorimetry 

Differential scanning calorimetry (DSC) measurements were performed on 

a DSC 2920 -TA lnstruments. DSC curves of chitosan membranes (C1 and 

C2) were obtained by heating samples from -130 "C up to 200 o C, at 

heating rate of 2° C min·1 and modulation rate ±1 o C min·1 , under nitrogen 

atmosphere, in arder to estimate glass transition and melting temperatures. 

Scanning Electron Microscopy 

Chitosan membranes samples were cut and kept in a vacuum desiccator 

for 48 hours. Then, samples were coated with gold/paladium using a SC 

7620 Sputter Coater - POLARON under high vacuum and 4 mA for 180 

seconds. Coated samples were examined using a LEO 440i Scanning 

Electron Microscopy (SEM). 

Water solubility and humidity 

Percentage of humidity in chitosan membranes was determined by 

gravimetric method. Circular membranes samples (0=2 em) were kept in a 

vacuum desiccator for 24 hours and weighed to obtain the initial mass (Mi). 

After this procedure, they were dried at 100° C for 24 hours and weighed 

again ·m arder to determine the final mass (Mf). 

The percentage of humidity was calculated according to the following 

24 



equation: 

H(%)= (Mi- Mf) * 100 I Mi (Eq. 1) 

Chitosan membranes water solubility was determined according to 

Gontard et al. 191 . Circular samples (D=2 em) were dried at 100° C for 24 

hours and weighted to obtain their dry mass (Wi). After this procedure, they 

were immersed into 50 ml of water for 24 hours at 25° C by slowly string. 

Samples were then taken out and dried (1 00 o C for 24 hours) to determine 

the membrane weight not soluble in water (Wf). The percentage of water 

solubility (W) was calculated from the following equation: 

W(%) = (Wi- Wf) * 100 I Wi (Eq. 2) 
Each experiment was repeated three times and the average value was 

calculated. 

Swelling behavior 

Swelling behavior of chitosan membranes was determined by the 

gravimetric method. Square membranes samples (L=2 em) were kept in a 

vacuum desiccator for 24 hours and their dry mass (Wo) were determined. 

After this procedure, they were immersed in pH 7.4 and 5.6 of phosphate 

buffer saline solution at 37 CC. After pre-determined periods (5, 20, 40, 60, 

80, 100, 120 and 180 minutes), wet weights (Ww) of chitosan membranes 

were determined by first blotting the membranes with filter paper to remove 

adsorbed water on the surface, then immediately weighted on an electronic 

scale. The swelling ratio (S) of chitosan membranes in the media was 

calculated from the following equation: 

S(%) = (Ww- Wo) * 100 I Ww (Eq. 3) 
Each experiment was repeated three times and the average value was 

taken as the swelling ratio. 

Mechanical properties 

Eletronic Digital Caliper (Fowler &amp;amp; NSK - Max-Cal) was used to measure 

25 



membranes thickness (õ). TA-XT2 (SMS, Surrey, UK) instrument was used 

to measure tensile strength (TS) and percent elongation at break (E). Tests 

were carried out according to ASTM D-882[101 , with initial grip separation of 

50 mm and cross head speed of 60 mm/min. TS was calculated by dividing 

the maximum load for breaking film by cross sectional area and E was 

determined by dividing film elongation at rupture by initial gauge length and 

multiplying by 1 00%. 

Results and discussion 

Oifferential Scanning Calorimetry 

DSC results are presented in Table 1. 

Table 1. Thermal properties of chitosan membranes. 

Sample Tg1 Tg2 Tga Tm ~H 
"C "C "C "C J/g 

C1 -81.70 -84.1 o -73.69 101.95 458.70 
C2 -76.90 -75.63 -73.16 88.39 418.50 

DSC analysis presented lower value of glass transition temperature for C1 

and lower values of enthalpy and melting temperature for C2. lt can be 

attributed to acetic acid molecules that act as plastcizer in C1, increasing 

its mobility. On the other side, neutralization process removes acetic acid 

molecules from C2 and promotes a molecular rearrangement of polymer 

chains, which is responsible for a decrease in the free volume of the 

system and an increase in its glass transition temperature. 

Scanning Electron Microscopy 

C1 and C2 scanning electron micrographs are presented in Figures 1 and 

2, respectively. SEM micrographies showed that C1 surface is more 

regular than C2 surface, which presented some rugosity. lt may be 

attributed to the neutralization process that removes superficial acetic acid 

molecules from C2. Moreover, they showed that both C1 and C2 are dense 

and packed membranes. 

26 



Figure 1. Superficial and Internai morphologies of C1. 

Figure 2. Superficial and Internai morphologies of C2. 

Water so/ubility and humidity 

Some parameters such as percentage of humidity (H) and of water 

solubility (S); thickness (li), tensile strength (TS) and percent elongation at 

break (E) obtained for C1 and C2 membranes are presented in Table 2. 

T able 2. Properties of chitosan membranes. 

Sample H w ô TS E 
% % Jlm MPa % 

C1 17.42 20.28 40 j 22.31 23.45 
C2 j 2. j j 2.34 50 140.54 8.04 

Chitosan is insoluble in neutral and alkaline media, but it is soluble in acid 

one. Residual acetic acid of C1 interacts with water and forms a weak acid 

solution. For this reason, C1 is much more soluble than C2. The largest 

humidity of C1 compared to C2 one can be attributed to the presence of 

acetic acid molecules in C1, which increases its hydrophilic character. 

27 



Swelling behavior 

Swelling behavior of C1 and C2 at different pH's is presented in Figure 3. 

100 

·======~------· • 
90 ·-·-·-· • 
80 

70 

~ 60 ~: x::::::=:---=---...-: .. o 
""§ 50 

"' ª 40 a; ----c1 pH 7.4 ~ 30&amp;lt;f) --+-C1 pH 5.6 
20 --4&gt;-- C2 pH 7.4 

--T- C2 pH 5.6 
10 

o 
o 20 40 60 80 100 120 140 160 180 200 

Time (min) 

Figure 3. Swelling behavior of chitosan membranes at pH 7.4 and 5.6. 

According to Figure 3, C1 presented higher water absorption in acid 

medium (pH 5.6) than in physiological medium (pH 7.4). lt can be 

attributed to the protonation of chitosan amine groups in acid medium, that 

increases its hydrophilicity. As soon as C1 was immersed in pH 5.6 

solution, it swelled and presented a gel aspect, which had lead to a more 

difficult removal of adsorbed water on the surface. Samples immersed in 

that solution for 120 and 180 minutes could not be totally taken off, since 

part of them were dissolved. This fact can explain the swelling ratio 

decreasing for those times. When immersed in pH 7.4 solution, C1 also 

swelled and got a gel consistence. However, it was only observed in the 

first three points (5, 20 and 40 minutes). After those periods, C1 probably 

reached the equilibrium state with the medium and its water absorption 

was decreased. 

C2 swelling ratio was also higher in acid medium due to protonation of 

amine groups. Nevertheless, when compared to C1 swelling ratio, C2 one 

was lower in both pH solution. This can be attributed to neutralization 

process that removed acetic acid molecules from C2 and decreased its 

hydrophilicity. 

28 



Swelling behavior is an important parameter for wound dressing 

management. An ideal wound dressing should absorb fluids excreted by 

the wound to avoid accumulation of fluid between wound and dressing 

because of the risk of infection[131 . However, wound dressing should 

maintain its properties to continue replacing skin lost functions. In that way, 

C2 presented better results than C1, because it maintained its shape and 

consistence when swollen. 

Mechanical properties 

Skin is a viscoelastic material and is permanently subjected to slight stress. 

Tensile strength of skin is very dependent on the rate of loading and varies 

with the direction of the stress. Moreover, it is different depending on the 

gender, age and site. An average tensile strength of 1.8 kgf mm-2 (-17.6 

MPa) was quoted by Wohlish[11 1. However, tensile strength of wounds is 

weaker than skin one and varies during wound healing process.l121 

Tensile Strength (TS) and percent Elongation at break (E) of C1 and C2 

are presented in Table 2. C1 presented lower tensile strength and higher 

elongation at break than C2, what can be explained by the presence of 

acetic acid molecules in C1, that act as plasticizer, lowering the tensile 

strength and improving the elongation at break. 

According to skin tensile strength average, both chitosan membranes can 

replace mechanical functions of lost skin, due to their tensile strength 

almost 1 O times higher than the skin. 

Conclusions 

Neutralization process promoted a molecular rearrangement on C2 due to 

acetic acid molecules remova! and decreased free volume around the 

polymer chains. In addition, neutralization process reduced water solubility, 

humidity and water sorption of chitosan membrane by removing hydrophilic 

groups (acetic acid). An improvement on chitosan membrane tensile 

strength and a decrease on its elongation at break were observed after 

neutralization process and they were also attributed to the remova! of 

acetic acid molecules that acted as a plasticizer. 

29 



Finally, neutralization process is an important step on preparation of 

chitosan membranes as a biomaterial for wound dressing; and also this 

process retards acid hidrolysis of chitosan. 

References 

[1] E. B. Denkbas, E. Óztürk, N. Ózdemir, K. Keçeci, Journal of 

Biomaterials Applications 2004, 18, 291 . 

[2] F. H. Silver, in "Biocompatibility - lnteractions of biological and 

implantable materiais" 1949, Vol.1: Polymers; 

[3] M. Fwu-Long, S. Shyu, V. Wu, S. Lee, J. Shyong, R. Huang , 

Biomaterials 2001, 22, 165. 

[4] G. Molinaro, J. Leroux, J. Damas, A. Adam, Biomaterials 2002, 23, 

2717. 

[5] K. Kurita, Polymer Application and Stability 1998, 59, 117. 

[6] R. A. A. Muzzarelli, Cell Moi. Life Sei. 1997, 53, 131. 

[7] J. Synowiecki, N. A. AI-Khateeb, Food Science and Nutrition 2003, 43, 

145. 

[8] J. Berger, M. Reist, J. M. Mayer, N. A. Peppas, R. Gurny, European 

Journal of Pharmaceutics and Biopharmaceutics 2004, 57, 19. 

[9] N. Gontard., C. Duchez, J-L. Cuq, S. Guilbert, lnternational Journal of 

Food Science and Technology, 1994, 29, 39. 

[1 O]ASTM - Tensile properties of thin plastics sheeting. Annual Book of 

ASTM Standards, American Society for Testing and Materiais, 

Philadelphia, D 882, 1995. 

[11] E. Wollisch, Z. Kolloid, 1943, 14, 104. 

[12] H. L. Elden, in "Byophisical Properties of the Skin", John Wiley &amp;amp; 

Sons, Inc. 1971, 13, 453. 

[13] K. Matsuda, S. Suzuki, N. lshiki, V. lkada, Biomaterials 1993, 14, 

1030. 

30 



Antibacterial Activity of Chitosan Solutions for Wound Dressing 

Publicado na Revista Macromolecular Symposia, vai. 245-246, p. 515-

518,2006- DOI: 10.1002/masy.200651373. 

Atividade Antibacteriana de Soluções de Quitosana para 

Recobrimento de Feridas 

Maria Campos,·; Lívia Cordi, 1' 2 Nelson Durán, 2 Lucia Mei 1 

1 
Faculdade de Engenharia Química, Universidade Estadual de Campinas, Caixa Postal 

6066, Campinas/SP, Brasil Fax: (+55)19 3521 3938; 

E-mail: gabi@feg.unicamp.br 

2 
Instituto de Química, Universidade Estadual de Campinas, Caixa Postal 6154, 

Campinas/SP, Brasil 

Resumo: A quitosana tem encontrado ampla aplicação no campo 

biomédico devido às suas interessantes propriedades biológicas que 

incluem: biocompatibilidade, biodegradabilidade, atividade hemostática e 

efeito bacteriostático. Neste presente trabalho, a atividade antibacteriana 

das soluções de quitosana para recobrimento de feridas foi investigada 

contra Staphylococcus aureus (isolada de um lodo ativado) e Escherichia 

co/i (ATCC 25922) que são patógenos de feridas em potencial. Além 

disso, os efeitos da adição de plastificante e da concentração da solução 

de quitosana na atividade antibacteriana foram avaliados. De acordo com 

o estudo da atividade antibacteriana, as soluções de quitosana, 

plastificadas ou não, mostraram, atividade inibitória ao crescimento de 

Escherichia co/i. Entretanto, elas não inibiram o crescimento de 

Staphy/ococcus aureus, possivelmente pelo fato desta cepa de bactéria ter 

se tornado resistente devido à mutações causadas pela exposição a 

efluente industrial. 

Palavras-chave: quitosana; recobrimento de ferida, atividade 

antibacteriana. 

31 



Antibacterial Activity oi Chitosan Solutions for Wound Dressing 

Maria Campos, ' 1 Lívia Cordi, 1•2 Nelson Ourán,' Lucia Mei
1 

1 Faculty of Chemical Engineering, State University of Campinas-

UNICAMP, P.O.Box 6066, Campinas/SP, Brazil Fax: (+55)19 3521 3938; 

E-mail: gabi@feg.unicamp.br 

2 Chemistry lnstitute, State University of Campinas-UNICAMP, P.O.Box 

6154, Campinas/SP, Brazil 

Summary: Chitosan has found wide application in lhe biomedical field due 

to its interesting biological properties that include: biocompatibility, 

biodegradability, hemostatic activity and bacteriostatic effect. In this 

present study, antibacterial activity of chitosan solutions for wound 

dressing were investigated against Staphylococcus aureus (isolated from 

an activated sludge) and Escherichia co/i (ATCC 25922) that are potential 

wound pathogens. Moreover, the effects of plasticizer addition and 

chitosan concentration on antibacterial activity of chitosan solutions were 

also evaluated. According to the antibacterial activity study, chitosan 

solutions, plasticized or not, showed inhibitory activity against Escherichia 

co/i. However, they did not inhibit Staphy!ococcus aureus growth, possibly 

because this bacterium strain would become resistant due to mutations 

caused by industrial effluent exposure. 

Keywords: chitosan; wound dressing; antibacterial activity 

lntroduction 

Chitosan is a cationic copolymer obtained by alkaline deacetylation of 

chitin, which is a natural polymer derived from marine crustaceans' 

exoskeletons. Chitosan exhibits numerous interesting properties, such as 

antitumoral, immune-adjuvant, hemostatic and antibacterial activities1' 1• 

Moreover, it is considered as a biocompatible and biodegradable polymer 

and has been shown to facilitate wound healingl21. 

Due to its interesting biological properties, chitosan has been increasingly 

32 



used in severa! medicai applications such as drug delivery systems, 

implants, injections and wound dressing'' '1• Chitosan solutions h ave been 

used for treatment of skin wounds, such as skin ulcers, burns and surgical 

wounds. 

The antimicrobial activity of chitosan has been studied extensively. lt has 

been shown lha! chitosan acts by disrupting the barrier properties of the 

outer membrana of Gram-negative bacteria[61. 

In this present study, the effects of chitosan concentration and plasticizer 

addition on the antibacterial activity of chitosan solutions for wound 

dressing were investigated. D-sorbitol, a biocompatible poly-alcohol 

commonly used along with chitosan, was added as a plasticizer. Besides, 

the antibacterial activity of chitosan solutions was evaluated against two 

potential Gram-negative wound pathogens: Staphy/ococcus aureus and 

Escherichia co/i. 

Staphy/ococcus aureus, the most common bacteria to cause skin wound 

infections171 , was isolated from an activated sludge. The activated sludge 

process is a wastewater treatment method in which the carbonaceous 

organic matter of wastewater providas an energy source for the production 

of new cells for a mixed population of microorganisms in an aquatic 

aerobic environment. Bacteria constitute the majority of microorganisms 

present in activated sludge. Both aerobic and anaerobic bacteria may exist 

in the activated sludge, but the preponderance of species is facultative, 

since they are able to live in either the presence of or lack of dissolved 

oxygen. In addition, due to the complex environment found in activated 

sludge, bacteria may suffer mutation, transformation and recombination. 

Escherichia co/i ATCC 25922, widely applied for antibiotic susceptibility 

assays, was used as a contrai Gram-negative bacterium!81. 

Experimental 

Materiais 

High molecular weight chitosan (Mw - 100,000), more than 75% 

deacetylated, and D-sorbitol were purchased from Aldrich Chemical 

33 



Company (USA). Glacial acelic acid was purchased from Synlh (Brazil). 

Staphy/ococcus aureus was isolaled from an aclivaled sludge (collected 

from a Wasle Trealmenl Planl) by Seleclive Medium Technique and 

identified by Molecular Melhod. Escherichia co/i American Type Cullure 

Collection (ATCC) 25992 was gently supplied by Dr. Marcelo Brocchi from 

the Department of Microbiology-lnstitute of Biology al UNICAMP-Brazil. 

Preparation of chitosan so/utions 

Solutions were prepared according to T able 1. Acetic acid 1.0% was used 

as solvenl and D-sorbitol 1.0% as plasticizer. 

Chitosan flakes were dissolved in acetic acid aqueous solulion. Then, lhe 

solulion was fillered to eliminale insoluble impurities. Plasticized chitosan 

solulion was prepared by adding D-sorbitol to the filtered chitosan solution 

and the plaslicizer solution was prepared by dissolving D-sorbitol in acelic 

acid aqueous solution. 

Table 1-Solulions contenls and concentrations (w/w). 

Solution Chitosan (%) D-sorbitol (%) 

Ac 1.0% (solvenl) o o 
Ch 0.5% 0.5 o 
Ch 1.0% 1.0 o 
Ch 1.5% 1.5 o 

Ch 1.5%-So 
1.5 1.0 

1.0% 

So 1.0% o 1.0 

Antibacterial Activity Study 

Both bacteria, Staphy/ococcus aureus and Escherichia co/i, were 

independently grown in nutrienl broth for 24 hours at 37 'C. The number of 

Colony-Forming Units (CFU/ml) was determined by lhe Serial Dilutions 

Method. According to this method, 3.0"1 04 CFU/ml of Staphy/ococcus 

aureus and 2.0"1 03 CFU/ml of Escherichia co/i were counled. 

34 



The antibacterial activity study was carried out by agar diffusion technique: 

30 ml of PCA (Piate Count Agar) were added to each Petri dish and then 

inoculated with 0.1 ml of bacterial solution ( Staphylococcus aureus or 

Escherichia cof1). Wells of 0.7 mm diameter were punched in the center of 

each Petri dish and 0.1 ml of test solution (Table 1) was applied to each 

well. 

After 24 hours of incubation at 37"C, bacterial growth's inhibition zones 

were measured around lhe wells. This antibacterial activity study was 

carried out in triplicates. 

Results and Discussion 

According to antibacterial activity study results presented in Figures 1 and 

2, ali solutions inhibited Escherichia coli growth. lt was expected that 

higher concentration of chitosan would inhibit more bacterial growth. 

However, Ch 0.5% showed the strongest antibacterial activity, while Ch 

1.5% showed the weakest one. 

This unexpected behavior can be attributed to the viscosity of chitosan 

solutions, which increases when chitosan concentration rises. Thus, high 

viscosity solutions delay chitosan diffusion in agar, while low viscosity 

solutions permit fast flow. 

Plasticizer addition decreases solution viscosity 19l that explains stronger 

inhibitory activity of Ch 1.5%-So 1.0% when compared to Ch 1.5%. D-

sorbitol and acetic acid also showed antibacterial activity against 

Escherichia coli. 

Chitosan kills bacteria through cell membrane damage. lt increases the 

permeability of the outer and inner membranes and ultimately disrupted 

bacterial cell membranesl10l. These damages are caused by electrostatic 

interactions between chitosan protonated amino groups and phosphoryl 

groups of phospholipid components of cell membranes. 

35 



2.5 

8 o 
2 -

11.5 +-l;7,fiil- ----1 
"O 
v 
c 
2 

:~ 
"' :.a 05 .5 ·-

o 
Ch 0.5% Chl.O% Ch 1.5% Ch 1.5%- Ac 1.0% So 1.0% 

So 1.0% 

Figure 1-lnhibition zones diameter (em) of chitosan, D-sorbitol and acetic 

acid solutions on Escherichia co/i growth. 

For these reasons, it was expected that chitosan solutions would inhibit 

Staphylococcus aureus growth. However, inhibition zones were not 

observed in Petri dishes inoculated with this bacterium. Probably, this 

bacterium strain, isolated from an activated sludge, would become 

resistant to chitosan due to mutations caused by industrial effluent 

exposure. 

Conclusions 

Chitosan solutions showed antibacterial activity against Escherichia co/i 

and their inhibitory activity was inversely proportional to chitosan 

concentration. Moreover, D-sorbitol decreased viscosity of chitosan 

solution and increased its antibacterial activity. 

Chitosan did not show inhibitory activity against Staphy/ococcus aureus 

that probably has became resistant to chitosan due to mutations caused by 

chemical effluent contact. 

36 



Figure 2- (a) Ch 1.0% with Escherichia co/i; (b) Ch. 1.5%-So 1.0% with 

Escherichia co/i; (c) Ch 1.5% with Escherichia co/i; (d) So 1.0% with 

Escherichia co/i; (e) Ch 1.0% with Staphylococcus aureus. 

Acknowledgments 

The authors thank CNPq and CAPES for financiai support. 

References 

[1] K. Kurita. Polym Degrad Stabil. 1998, 59, 117. 

[2]J.Berger. Eur J Pharm Biopharm. 2004, 57, 19. 

[3] C. Hoemann. Osteoarthr Cartilage. 2005, 13, 318. 

[4] E. Denkbas. J Biomater Appl. 2004, 18, 291. 

[5] H. Ueno. Adv Drug Deliver Rev. 2001, 52, 105. 

[6]1. M.Helander. lnt. J. Food Microbiol. 2001, 71, 235. 

[7] P. G. Bowler. Clin Microbiol Rev. 2001, 14, 244. 

[8] J. V. Uri. Acta Microbiollmmunol Hung. 1994, 41 (2), 215. 

[9] N. Suyatma. J Agr Food Chem. 2005, 53, 3950. 

[10] H. Liu. lntJ Food Microbiol. 2004, 95(2), 147. 

37 



4.3 In Vitro Cytotoxicity Evaluation of Chitosan Membranes for Wound 
Dressing 

Publicado nos Anais do IV Congresso Latino Americano de Órgãos 

Artificiais e Biomateriais- COLAOB 2006. 

AVALIAÇÃO IN VITRO DA CITOTOXICIDADE DE MEMBRANAS DE 

QUITOSANA PARA RECOBRIMENTO DE FERIDAS 

Arnaldo R. Santos Jr1 , Maria G. N. Campos2 , and Lucia H. lnocentinni-Mei2 

1 Deparatmento de Biologia Aplicada, Faculdade de Ciências Agrárias e Veterinária, 

Universidade do Estado de São Paulo, UNESP, Brasil, arsantosjr@yahoo.com.br 

2Departamento de Tecnologia de Polímeros, Faculdade de Engenharia Química, 

Universidade Estadual de Campinas, UNICAMP, Brasil 

Resumo: Três formulações de membranas de quitosana para 

recobrimento de feridas foram preparadas variando-se a adição de 

plastificante e o processo de neutralização. D-sorbitol foi usado como 

plastificante e NaOH-Na2C03 como solução neutralizadora. O objetivo 

deste presente estudo foi avaliar a citotoxicidade in vitro das membranas 

de quitosana usando os testes de citotoxicidade Direta e Indireta. As 

células Vero, uma linhagem celular derivada do rim do macaco verde 

africano, foram escolhidas para a avaliação da citotoxicidade. As 

membranas de quitosana não mostraram citotoxicidade indireta, 

entretanto, quando em contato direto com as células Vero, evidências de 

citotoxicidade foram observadas para a membrana não neutralizada. Esta 

citotoxicidade direta foi atribuída ao ácido acético residual, já que o ácido 

acético é tóxico para as células. As membranas neutralizada e plastificada 

não foram diretamente tóxicas para as células e o D-sorbitol foi 

considerado um plastificante seguro e não-tóxico. 

Palavras-chave: quitosana, membranas, recobrimento de feridas, 

citotoxicidade, cultivo de células, células Vero. 

38 



IN VITRO CYTOTOXICITY EVALUATION OF CHITOSAN 

MEMBRANES FOR WOUND DRESSING 

Arnaldo R. Santos Jr1 , Maria G. N. Campos2 , and Lucia H. lnocentinni-Mei2 

1 Department of Applied Biology, Faculty of Agrarian and Veterinary 

Sciences, São Paulo State University, UNESP, Brazil, 

arsantosjr@yahoo.com.br 

2 Department of Polymer Technology, Faculty of Chemical Engineering, 

State University of Campinas, UNICAMP, Brazil 

Abstract: Three formulations of chitosan membranes for wound dressing 

were prepared by varing the plasticizer addition and the neutralization 

process. D-sorbitol was used as plasticizer and NaOH-Na2C03 as 

neutralizer solution. The purpose of this present study was to evaluate the 

in vitro cytotoxicity of these membranes by using lndirect and Direct 

Cytotoxixty Tests. Vero cells, a cell line derived from the kidney of the 

African green monkey, were chosen for cytotoxicity evaluation. Chitosan 

membranes did not show lndirect cytotoxicity, however, when on direct 

contact to Vero Cells, cytotoxicity evidences were observed for the non-

neutralized membrane. This direct cytotoxicity was attributed to residual 

acetic acid present in this membrane, since acetic acid is toxic to cells. 

Neutralized and plasticized membranes were not directly toxic to cells and 

D-sorbitol was considered a safety and non-toxic plasticizer. 

Key words: Chitosan, Wound dressing, Cell culture, D-sorbitol, 

Membranes. 

1. INTRODUCTION 

Chitosan is a partially deacetylated derivative of chitin, which is the second 

more abundant polysaccharide found in nature and the primary structural 

polymer in arthropod exoskeletons (Yamane et ai., 2005). Chitosan has 

generated enormous interest as a biomaterial due to its various 

advantages such as (1) low cost, (2) easy availability, (3) biocompatibility 

39 



and (4) anti-microbial activity (Sarasam and Madihally, 2005). 

The potential of chitosan as a wound dressing is based on its cationic 

nature and high charge density in solution. lt was reported that the cationic 

nature of chitosan allows electrostatic interactions with anionic 

glycosaminoglycans and proteoglycans (Madihally et ai., 1999), that may 

serve as a mechanism for retaining and recruiting cells, growth factors, and 

cytokines in the wound healing process. 

Chitosan exhibits others interesting biological activities, such as anti-tumor, 

immuneadjuvant, and hemostatic activities (Kurita, 1998) and is considered 

biodegradable (Muzzarelli, 1997). Due to its positive charges at 

physiological pH, chitosan is bio-adhesive, which increases its retention on 

the site of application (Berger, 2004). lt also can accelerate wound healing 

(Synowiecki, 2003). For ali those reasons, chitosan is one of the most 

important biomaterials for wound dressing management in the recent 

years. 

Chitosan is soluble in acetic acid and can easily form films and 

membranes. However, plasticizers can be used to improve its mechanical 

properties. In this present study, D-sorbitol, a bio-compatible poly-alcohol, 

was used as plasticizer, in arder to evaluate its effects on chitosan 

membranes' cytotoxicity. 

2. MATERIALS ANO METHODS 

Preparatíon of Chítosan Membranes. 

Chitosan membranes were prepared by solvent evaporation technique by 

using acetic acid (1.0 % w/w) as solvent. Chitosan solution was prepared 

by dissolving 1 .5g of chitosan in 1 00 ml of solvent. After total dissolution, it 

was filtered to remove impurities. Chitosan membrane (CA) was obtained 

by casting the chitosan solution in a Petri dish and drying in an oven at 40º 

C. Neutralized chitosan membrane (CN) was prepared by immersing CA 

into NaOH (2% w/w)- Na2Co3 (0.05% w/w) aqueous solution for 1 hour. 

After immersion, CN was repeatedly washed with distillated water and 

dried at 40 o C. 1.0g of D-sorbitol was added to chitosan solution in arder to 

40 



prepare the plasticized membrane (CP), which was obtained by casting the 

plasticized solution in a Petri dish and drying at 40º C. Chitosan 

membranes (CA, CP and CN) were sterilized by ethylene oxide exposure 

for 8 hours at 40"C, according to sterilization procedures. 

Cytotoxicity Assay. 

For cytotoxicity evaluation, Vero Cell p240, a cell line derived from the 

kidney of the African green monkey, Cercopithecus aeothips, was 

cultivated in a Ham's F1 O Nutrition Media (Sigma/USA), supplemented with 

10% Fetal Calf Serum (Nutriceii/Brazil). Cytotoxicity Tests were carried out 

according to ISO 1 0993-5. 

lndirect Cytotoxicity Test was carried out according to Mossmam's 

Methodology (Mossmam, 1983). 10% Phenol solution was used as toxicity 

positive contrai and polypropylene (culture plate) as negative one. Viable 

cells number was determined by Spectrophotometric Analysis (8 = 540 nm) 

by using MTT solutions (Sigma/USA) for cell detection. 

3. RESUL TS ANO DISCUSSION 

Cytotoxicity testing is a rapid, standardized, sensitive and inexpensive 

method to determine if a material contains significant quantities of 

biologically harmful extractable. Besides, it can provide predictive evidence 

of material biocompatibility. Direct toxicity test (DT) consisted of assessing 

possible toxic effects of chitosan membranes on direct contact to cells, 

while indirect toxicity test (IT) evaluates potential deleterious effects of 

substances released in the culture medium by chitosan membranes. 

IT results (Fig.1) indicated that CA, CP and CN did not release toxic 

substances to the culture media. Chitosan membranes (CA, CP and CN) 

presented viable cell number higher than negative contrai one, what can 

be attributed to chitosan's biological property of stimulates cell proliferation 

(Muzzarelli, 1988). 

On the other side, DT for CA presented cell aggregation, cytoplasm 

reduction and cell death after 48 hours of Vero cell incubation. CA direct 

toxicity may be attributed to residual acetic acid, which was found to be 

41 



cytotoxic and unsuitable for wound care (Lineaweaver, 1985). 

Direct cytotoxicity evidences were not observed for CP and CN and both 

membranes were considered satisfactory as cell growth scaffolds. 

lndirect Cytotoxicity 

0.4,----------------------------------------, 

0.35 +---------------------.--------..---------1r---1 

e 0.3 +---+--------------
0 

;i!; 0.25 
$ 
~ 0.2 
] 
~ 0.15 
o 
] 0.1 
&amp;lt;

0,05 

o 
Negative 
Control 

Pnsitíve 
Contrai 

CN 

Sampies 

CA CP 

Figure 1 - lndirect cytotoxicity test for Chitosan Membranes. 

4. CONCLUSIONS 

Chitosan membranes' cytotoxicity was evaluated by direct and indirect 

tests. CA, CP and CN did not present indirect cytotoxicity. However, when 

on direct contact to Vero cells, CA showed cytotoxicity evidences, probably 

due to residual acetic acid. CP and CN did not present direct toxic effects 

on Vero cells and D-sorbitol was considered a non-toxic plasticizer. 

Finally, neutralization is an important step in lhe preparation of chitosan 

membranes for wound dressing, since it removes residual acetic acid, 

which was found to be toxic to cell's growth. 

5. REFERENCES 

Berger, J., Reist, M., Mayer, JM, Felt, O. and Gurny, R. (2004) "Structure and 

lnteractions in covalently and ionically crosslinked chitosan hydrogels for 

biomedical applications", European Journal oi Pharmaceutics and 

Biopharmaceutics vol 57, 19·34. 

42 



lnternational Standard (1992): Biological evaluation of medicai devices - Part 5. 

Tests for cytotoxicity: in vitro methods. 

Kurita K., (1998) "Chemistry and Application of chitin and chitosan", Polymer 

Application and Stability, vol 59,117-120. 

Lineaweaver W. Seeger J. Andei A. Rumley T. Howard R., (1985) "Neutrophil 

delivery to wounds of the upper and lower extremities", Archives of Surgery, vol 

120(4),430-431. 

Madihally SV, Matthew HW., (1999) "Porous chitosan scaffolds for tissue 

engineering", Biomaterials, vol20,1133-1142. 

Mossmam T.J., (1983) "Rapid colorimetric assay for cellular grow1h and survival: 

application to proliferation and cytotoxicity assays", Journal of lmmunological 

Methods, vol 65, 55-63. 

Muzzarelli R, Baldassarre V, Conti F, Ferrara P, Biagini G, Gazzanelli G, et ai., 

(1988) "Biological activity of chitosan: ultrastructural study", Biomaterials, vol 9(3), 

247-252. 

Muzzarelli R. A. A., (1997) "Human enzymic activities related to lhe therapeutic 

administration of chitin derivatives", Cellular and Molecular Life Sciences, vol 53, 

131-140. 

Sarasam, A., Madihally, S. V., (2005)"Characterization of chitosan-

polycaprolactone blends for tissue engineering applications", Biomaterials, vol 26, 

5500-5508. 

Synowiecki J., (2003) "Production, Properties, and Some New Applications of 

Chitin and lts Derivatives", Food Science and Nutrition, vol 43(2), 145-171. 

Yamane, S., lwasaki, N., Majima, T., Funakoshi, T., Masuko, T., Harada, K., 

Minami, A., Monde, K.,Nishimura, S-1., (2005) "Feasibility of chitosan-based 

hyaluronic acid hybrid biomaterial for a novel scaffold in cartilage tissue 

engineering", Biomaterials, vol 26, 611-619. 

AKNOWLEDGENTS 

The authors thank CNPq and CAPES for financiai support. 

43 



4.4 In vitro Cytotoxicity of Chitosan Membranes against Vero cells 

Submetido ao Journal of Materiais Research- Part B: Materiais in Medicine 

- manuscript number: JMSM970. 

Citotoxicidade in vitro de Membranas de Quitosana contra células 

Vero 

Arnaldo R. Santos Jr1, Maria G. N. Campos2, and Lucia H. lnocentinni-Mei2 

1Deparatmento de Biologia Aplicada, Faculdade de Ciências Agrárias e Veterinária, 

Universidade do Estado de São Paulo, UNESP, Brasil, arsantosjr@yahoo.com.br 

2 Departamento de Tecnologia de Polimeros, Faculdade de Engenharia Química, 

Universidade Estadual de Campinas, UNICAMP, Brasil 

Resumo: Três formulações de membranas de quitosana para 

recobrimento de feridas foram preparadas variando-se a adição de 

plastificante e o processo de neutralização. D-sorbitol foi usado como 

plastificante e NaOH-Na2C03 como solução neutralizadora. O objetivo 

deste presente estudo foi avaliar a citotoxicidade in vítro das membranas 

de quitosana usando os testes de citotoxicidade Direta e Indireta. As 

células Vero, uma linhagem celular derivada do rim do macaco verde 

africano, foram escolhidas para a avaliação da citotoxicidade. As 

membranas de quitosana não mostraram citotoxicidade indireta, 

entretanto, quando em contato direto com as células Vero, evidências de 

citotoxicidade foram observadas para a membrana não neutralizada. Esta 

citotoxicidade direta foi atribuída ao ácido acético residual, já que o ácido 

acético é tóxico para as células. As membranas neutralizada e plastificada 

não foram diretamente tóxicas para as células e o D-sorbitol foi 

considerado um plastificante seguro e não-tóxico. 

Palavras-chave: quitosana, membranas, recobrimento de feridas, 

citotoxicidade, cultivo de células, células Vero. 

44 



In vitro Cytotoxicity of Chitosan Membranes against Vero Cells 

Arnaldo Rodrigues Santos Jr1 , Maria Gabriela Nogueira Campos2' and 

Lucia Helena lnocentinni-Mei2 

1Department of Applied Biology, Faculty of Agrarian and Veterinary 

Sciences, São Paulo State University, UNESP, Brazil 

2Department of Polymer Technology, School of Chemical Engineering, 

State University of Campinas, Cidade Universitária "Zeferino Vaz" P.O. 

Box 6066, Campinas/SP, Brazil. Fax: (+55 19) 3521-3938 E-mail: 

gabi@feq.unicamp.br 

ABSTRACT: Three formulations of chitosan membranes for wound 

dressing were prepared by varying plasticizer addition and neutralization 

process. D-sorbitol was used as plasticizer and NaOH-Na2C03 as 

neutralizer solution. The aim of this present study was to evaluate in vitro 

cytotoxicity of chitosan membranes by using lndirect and Direct 

Cytotoxicity Tests. Vero cells, a cell line derived from the kidney of the 

African green monkey, were chosen for cytotoxicity evaluation. Chitosan 

membranes did not show indirect cytotoxicity, however, when on direct 

contact to Vero Cells, cytotoxicity evidences were observed for non-

neutralized membrane. This direct cytotoxicity was attributed to residual 

acetic acid present in this membrane, since acetic acid is toxic to cells. 

Neutralized and plasticized membranes were not directly toxic to cells and 

D-sorbitol was considered a safety and non-toxic plasticizer. 

Keywords: Chitosan, membranes, wound dressing, cytotoxicity, cell 

culture, Vero cells. 

1 INTRODUCTION 

The loss or failure of an organ or tissue is one of the most frequent, 

devastating, and costly problems in human health care. Tissue 

engineering, is a new research filed that applies the principies of biology 

and engineering to the development of functional substitutes for damaged 

tissue. 

45 



Central to successful tissue engineering is the ability of cells to adhere to 

an extra cellular material and proliferate. This ability mainly depends on the 

interactions between the cells and the material surface. Thus, an ideal 

scaffold for tissue engineering should demonstrate considerable 

mechanical properties, suitable biodegradability and, most importantly, 

good biocompatibility. 

Chitosan is a partially deacetylated derivative of chitin, which is the second 

more abundant polysaccharide found in nature and the primary structural 

polymer in arthropod exoskeletons [Yamane et ai., 2005]. Chitosan has 

generated enormous interest as a biomaterial due to its various 

advantages such as (1) low cost, (2) easy availability, (3) biocompatibility 

and (4) anti-microbial activity [Sarasam and Madihally, 2005]. The potential 

of chitosan as a tissue engineering scaffold is based on its cationic nature 

and high charge density in solution. Due to its cationic nature, chitosan is 

allowed for electrostatic interactions with anionic glycosaminoglycans and 

proteoglycans [Madihally et ai., 1999]. These ionic interactions may serve 

as a mechanism for retaining and recruiting cells, growth factors, and 

cytokines within the tissue scaffold. 

Chitosan exhibits others interesting biological activities, such as anti-tumor, 

immune-adjuvant, and hemostatic activities [Kurita, 1998,]. Moreover, it is 

metabolized by certain human enzymes, especially lysozyme, and is 

considered biodegradable [Muzzarelli, 1997]. Due to its positive charges at 

physiological pH, chitosan is bio-adhesive, which increases its retention on 

the site of application [Berger, 2004]. lt can also accelerate wound healing 

[Synowiecki, 2003]. 

Due to ali those properties, chitosan is one of the most important 

biomaterials for wound dressing management in the recent years. Chitosan 

can easily form films and membranes. However, plasticizers can be used 

to improve its mechanical properties. In this study, 0-sorbitol, a 

biocompatible poly-alcohol, was used as plasticizer, in order to evaluate its 

effects on chitosan membranes' cytotoxicity. 

46 



2 MATERIALS ANO METHODS 

2. 1 Chitosan membranes production 

Chitosan membranes were prepared by solvent evaporation. 1.0% (w/w) 

Acetic Acid (Synth/Brazil) solution was used as solvent. 1 .5g of High 

Molecular Weight Chitosan (Aidrich/USA) was dissolved in 1 00 ml of 

solvent. Then, chitosan membranes (CA) were obtained by casting 

chitosan solution in Petri dishes and drying at 40'C. 

1.0 g of D-sorbitol (Aidrich/USA) was added to chitosan solution in order to 

prepare plasticized membranes (CP). Neutralized membranes (CN) were 

prepared by immersing CA into NaOH (2% w/w)-Na2Co3 (0.05% w/w) 

aqueous solution for 1 hour. Then, CN were repeatedly washed with 

distillated water and dried at 40° C. 

Chitosan membranes (CA, CP and CN) were sterilized by ethylene oxide 

exposure for 8 hours at 40 'C, according to sterilization procedures. 

2.2 Ce/1 culture 

Vero cells are recommended for studies of cytotoxicity and for cell-

substratum interactions with biomaterials. This cell line was established 

from the kidney of the African green monkey (Cercopithecus aethiops) and 

obtained from Adolfo Lutz lnstitute, São Paulo, Brazil. 

Cells were cultured in Ham-F1 O medi um (Sigma) supplemented with 10% 

fetal calf serum (FCS, Nutricell Nutrientes Celulares, SP, Brazil) at 37'C 

and kept in culture flask of 25ml or 50ml before inoculation (Corning, 

Cambridge, MA, USA). Nutritional medium was replaced periodically. 

2.3 Cytotoxicity assay 

Vero cells were cultured on different chitosan membranes (CA, CP, and 

CN) for 24 hours. Six repetitions were made of ali experiments. Test was 

carried out according to Mossmann's Methodology [Mossmann, 1983]. 

Briefly, substrates were incubated in 96 well plates (Corning) with cultured 

medium without FCS for 24h at 37 o C. After this, 1 OOL L of cell suspension 

47 



(2.5 x 105 cells/mL) in Ham F-1 O with 1 O% of FCS was added to the wells 

containing different chitosan samples. 

Wells were washed twice with 0.1 M phosphate buffered saline (PBS) pH 

7.4, at 37"C and incubated with 100L L of Ham F-10 medium. The assay 

mixture (1 OL L per well) containing 5mg/mL of 3-(4,5-dimetiltiazol-2-il)-2,5 

diphenyl tetrazolium bromide (MTI, Sigma) was added to each well and 

incubated for 4h at 37"C. 

After 4h, 100~L of isopropanol acid (lsofar lnd, RJ, Brazil) was added to 

each well and 3 hours later, cells were quantified spectrophotometrically, 

based on absorbance at 540nm by using a Biorad Model 550 micro plate 

reader Spectrophotometer (Hercules, CA, USA). 

According to the ISO 1 0993-5, cells on poly-prapylene culture plate by 

themselves were used as positive contrai, while culture medium with 

phenol (2%) was used as negative toxicity contrai. Absorbance of ali 

experimental conditions (chitosan samples, negative or positive contrais) 

without cells was also read for MTI reaction contrai. 

Comparison of continuous variables for ali graups was dane with ANOVA. 

When a significant difference was found, Turkey HSD multiple comparison 

test was performed (p&amp;lt;0.05). 

2.4 Ce/1 morphology by Light microscopy and Scanning Electron 

microscopy 

For cell morphologic analysis by light microscopy (LM), 2.5 x 105 cells/mL 

were inoculated in 24 wells culture plate (Corning) containing a chitosan 

sample (CA, CP or CN) or one of the contrais (positive or negative). Cells 

were feed with Ham F-1 O medi um with 10% FCS. Alive cells were 

observed and photographed in inverted microscope IX-50 (Oiympus, 

Hatagaya, Tokyo, Japan) after 48h, 120h and 240h of cultured. For ali 

experiments, n=5. 

For cell morphologic analysis by scanning electron microscopy (SEM), 2.5 

x 105 cells/mL were inoculated on different chitosan membranes (CA, CP 

and CN) in 24 well cultured plate (Corning) feed with Ham F-1 O medium 

48 



with 10% FCS. Cells cultured on a glass cover slip, at the same culture 

conditions, were used as contrai. After 48h, samples were fixed in 3% 

glutaraldehyde (Sigma) in 0.1 M phosphate buffer at pH 7.2 for 45 minutes 

at 4'C, and post-fixed with 1% OS04 (Sigma) for 2h at 4'C. Specimens 

were then dehydrated in graded series of ethanol, criticai point dried 

(Balzers CDT 030) and coated with gold in a sputter coater (Balzers CDT 

050). The coated specimens were observed and photographed with a 

JEOL JSM-5800 scanning electron microscope. 

3 RESULTS 

3. 1 Cytotoxicity assay 

Cytotoxicity testing is a rapid, standardized, sensitiva and inexpensive 

method to determine whether a material contains significant quantities of 

biologically harmful extractable. Besides, it can provide predictive evidence 

of material biocompatibility. Direct cytotoxicity test consisted of assessing 

possible toxic effects of chitosan membranas on direct contact to cells, 

while lndirect Cytotoxicity test evaluates potential deleterious effects of 

substances released in the culture medium by chitosan membranes. 

lndirect Cytotoxicity results (Figure 1) indicated that CA, CP and CN did 

not release toxic substances to the culture media. Chitosan membranas 

(CA, CP and CN) showed viable cell number higher than negative contrai 

that can be attributed to chitosan's biological property of stimulates cell 

proliferation. 

On the other hand, for direct toxicity evaluation, a possible toxic effect of 

CA was observed (Figure 2). 

3.2 Ce/1 morphology by light microscopy 

For negative control (culture plate), spreading cells growing were found at 

ali incubation times studied. After 48hs and 120hs, we could observe a 

confluent cells monolayer on the culture plates. Round cells that indicate 

cell division could also be seen at these incubation times. Past 240hs, 

rounded cells on the substrate were found, indicating lost of viability. 

49 



Besides, numerous cells were observed flouting on the culture medium 

(Figures 3A). 

For positive contrai of toxicity (phenol), round and no viable cells on the 

substrate were observed for ali incubation times. The cell number at ali 

periods was, apparently, the same, indicating no cell proliferation on that 

samples (Figures 3B). 

ForCA sample, round and aggregated cells on the substrate were found at 

the first 48hs. However, cells aggregation was observed in small number. 

After 120hs of incubation, more spreading cells could be observed in the 

cellular aggregates. These cells were apparently trying to migrate for other 

regions of CA. Past 240hs, a no confluent cell layer on CA was observed 

(Figures 3C). 

Similar cell behavior was observed for CP and CN. However, at the first 

48hs, we observed a no confluent spreading cell monolayer on CP and CN 

samples. After 120hs, a confluent celllayer could be observed. Moreover, 

past 240hs of incubation, multi-layers of cells on CP and CN samples were 

found (Figures 3D and 3E, respectively). 

3.3 Ce/1 morphology by Scanning E/ectron Microscopy 

By SEM, retracted cell around cell fragments we found on CA. In 

some regions we could observe spreading cell near to cell fragments 

(Figures A1 and A2). We also could observe spreading cell on substrate on 

CP. In some regions, we found cell connected by thin processes (Figures 

B1 and B2). For CN, we observed spreading cells with large processes 

linking them. Many vesicles and/or microvillus were found on cell surface 

(Figures C1 and C2). 

4 DISCUSSION 

The indirect cytotoxicity indicated that there was no liberation of toxic 

substances from the different chitosan samples to the culture medium. On 

the other hand, CA showed some direct toxic activity in the MTT assay. 

This result was confirmed by the morphological pattern of Vero cells 

cultured on CA. Rounded and aggregated cells in small areas of CA were 

50 



observed. Morphological pattern was compatible with cells submitted to 

some toxic effect. After initial contact, some cells were capable to 

proliferate and migrate from cellular aggregates to CA surface. However, 

when compared to the other chitosan samples studied (CP and CN), CA 

showed small number of cells. CA direct toxicity can be attributed to 

residual acetic acid, which was found to be cytotoxicity and unsuitable for 

wound care [Lineaweaver, 1985]. 

lt was not observed direct cytotoxicity evidences for CP and CN and both 

membranes were considered satisfactory as cell growth scaffolds. CP and 

CN samples showed viable cell number higher than negativa contrai. Mori 

et ai. examined the effects of chitin and its derivatives on fibroblasts 

proliferation. Their results indicated that chitosan has no proliferation effect 

on in vitro fibroblasts growth [Mori et ai. 1997]. However, other reports 

showed that chitosan can indirectly accelerate fibroblast proliferation in 

vivo [Ueno et ai., 1999]. Ding et ai., when studied chitosan irnmobilization 

on PLLA surface, did not observe prominent effects of chitosan on cell 

proliferation (Ding et ai., 2004). Our results are in accordance to Mori et ai. 

and Ding et ai. since a decrease in the number of cells was observed for ali 

chitosan substrates (CA, CP and CN) when compared to the negative 

contrai (culture plate). 

Thus, our in vitro study results suggest that CP and CN can support the 

initial attachment and spreading of Vero cells. These findings are in 

accordance to previous reports that showed similar morphological pattern 

of cells cultured on chitosan surfaces. 

Microscopic observations at 1 h revealed that osteoblasts were attached 

and beginning to spread. In contras!, fibroblasts showed rounded 

morphologies with markedly reduced attachment leveis [Fakhryet ai., 

2004]. Previous reports have shown conflicting results about the effects of 

chitosan on fibroblasts. While chitosan has been shown to have stimulatory 

effect on fibroblast activity [Muzzarelli et ai., 1988; Lahiji et ai., 2000], other 

results have shown some inhibitory effects of chitosan on fibroblasts 

growth [Mori et ai., 1997; Berschtet ai., 1994]. 

51 



Mei et ai. showed the cell morphology on polycaprolactone (PCL) and 

chitosan-modified scaffolds. lt was reported that chitosan modification 

dramatically enhances cellular affinity and compatibility for PCL scaffolds. 

Cells were more firmly adhered on chitosan-modified PCL and more 

elongated and stretched on this substrate. Moreover, cell adhesion and 

proliferation on PCL scaffolds were considerably improved after chitosan 

modification [Mei et ai., 2005]. 

Conflicting results among published data on chitosan-mediate fibroblast 

cells attachment may be explained by differences in cell population 

analyzed and by variation in properties of tested chitosan [Fakhry et ai., 

2004]. 

After 240hs of incubation on chitosan samples, morphological analysis 

showed cells growing such as many layers. That growth pattern indicates a 

satisfactory proliferation of cells on those chitosan substrates. lt also 

indicates that CP and CN can support cellular growth after normal 

decrease of viability, as well observed in negative contrai for the same 

period of incubation. Our morphologic observations showed reduction of 

cell spreading in chitosan substrates when compared to culture plate 

(negative contrai). Similar trend was previously cited by Sarasam and 

Madihally who observed drastic decrease in the cell spreading area from 

contrai to chitosan [Sarasam and Madihally, 2005]. 

Cell spreading and morphology on chitosan substrates still are an unclear 

event. Structurally, chitosan is a linear polysaccharide consisting of L (1 L 4) 

linked D-glucosamine residues with variable number of randomly located 

N-acetyl-glucosamine groups. The average molecular weight ranges from 

50 to 1000 kDa [Yamane et ai., 2005]. Chitosan does not have one specific 

binding domain for cell adhesion mediated by integrins receptors. Also, any 

intracellular signaling pathway activated by chitosan contact is known 

[Hynes and Zhao, 2000]. Cells generally attach to an artificial culture 

substrate by binding to specific anchoring proteins that become adsorbed 

to substrate surface. Chitosan acts as a positively charged center in 

solution, and the outside of the cell membrane carries negative charges. 

52 



For Ding el ai., lhe eleclronic inleraclion belween cell and subslrate 

surface could modulate the cytoskeleton and cell morphology (Ding et ai., 

2004). On lhe other hand, Huang et ai. suggest that cell spreading and 

morphology could be modulated by the structural characteristics of 

chitosan scaffolds. In that work, authors seeded cells on bi-dimensional 

(2D) and three-dimensional (3D) chitosan substrates. On 2-D condition, 

cells were restricted to spread on a flat plane and the important factor 

affecting cellular activity was whether the substrate contains or no cell 

adhesion binding domains. In contras!, 3-D matrices provided spatial 

advantages for cell-cell and cell-matrix adhesion as well as support for cell 

traction [Huang et ai., 2005). Reduction in cell size was thought to be the 

result of strong electrostatic interactions associated with the deacetylation 

degree [Mao et ai., 2004). Changes on cellular activity induced by different 

deacetylation degrees could not be significantly relative to other adhesive 

forces [Huang et ai., 2005). Nevertheless, cells proliferation inhibition found 

on chitosan scaffolds could be due to reduced adhesion and not to strong 

adhesion [Mao et ai., 2004). 

5 CONCLUSIONS 

Chitosan membranes' cytotoxicity was evaluated by Direct and lndirect 

Tests. CA, CP and CN did not show lndirect Cytotoxicity. However, when 

on direct contact to Vero Cells, CA showed cytotoxicity evidences that 

were attributed to residual acetic acid. CP and CN did not show direct toxic 

effects on Vero Cells and D-sorbitol was considered a non-toxic plasticizer. 

Finally, neutralization was an important step in preparation of chitosan 

membranes for wound dressing because it removed residual acetic acid, 

which was found to be toxic for cells growth. 

6 REFERENCES 

Berger J, Reist M, Mayer JM, Felt O, Peppas NA, Gurny G. 2004, 

Structure and interactions in covalently and ionically cross linked chitosan 

hydrogels for biomedical applications, Eur J Pharm Biopharm, 57:19-34; 

53 



Berscht PC, Nies B, Liebendorfer A, Kreuter J. 1994, lncorporation of basic 

fibroblast growth factor into methylpyrrolidinone chitosan fleeces and 

determination of the in vitro release characteristics, Biomaterials, 15:593-

600; 

Ding Z., Chen J., Gao S., Chang J., Zhang J., Kang E. 2004, 

lmmobilization of chitosan onto poly-L-Iactic acid film surface by plasma 

graft polymerization to contrai the morphology of fibroblast and liver cells, 

Biomaterials, 25:1 059-1 067; 

Fakhry A. Schneider GB, Zaharias R, Senel S. 2004, Chitosan supports 

the initial attachment and spreading of osteoblasts preferentially over 

fibroblasts, Biomaterials, 25:2075-2079; 

Huang Y, Onyeri S, Siewe M, Moshfeghian A, Madihally SV. 2005, In vitro 

characterization of chitosan-gelatin scaffolds for tissue engineering, 

Biomaterials, 26:7616-7627; 

Hynes RO, Zhao Q. 2000, The evolution of cell adhesion, J Cell Biol, 

150:89-96; 

lnternational Standard, 1992, Biological evaluation of medicai devices -

Part 5- Tests for cytotoxicity: in vitro methods; 

Kurita K. 1998, Chemistry and application of chitin and chitosan, Polym 

Degrad Stab, 59:117-120; 

Lahiji A, Sohrabi A, Hungerford DS, Frondoza CG. 2000, Chitosan 

supports the expression of extracellular matrix proteins in human 

osteoblasts and chondrocytes. J Biomed Mater Res, 51 :586-595; 

Lineaweaver W, Howard R, Soucy D, et ai. 1985, Topical antimicrobial 

toxicity, Arch Surg, 120:267-270; 

Madihally SV, Matthew HW. 1999, Porous chitosan scaffolds for tissue 

engineering, Biomaterials, 20:1133 - 1142; 

Mao JS, Cui YL, Wang XH, Sun Y, Yin YJ, Zhao HM, et ai. 2004, A 

preliminary study on chitosan and gelatin polyelectrolyte complex 

54 



cytocompatibility by cell cycle and apoptosis analysis, Biomaterials, 

25:387- 391; 

Mei N, Chen G, Zhou P, Chen X, Shao Z-Z. 2005, Biocompatibility of 

Poly(e-caprolactone) Scaffold Modified by Chitosan - The Fibroblasts 

Proliferation in vitro, J Biomater Appl, 19: 323-339; 

Mori T, Okumura M, Matsuura M, Ueno K, Tokura S, Okamoto Y, Minami 

S, Fujinaga T. 1997, Effects of chitin and its derivatives on the proliferation 

and cytokine production of fibroblasts in vitro, Biomaterials, 18:947-951; 

Mossmann T J. 1983, Rapid colorimetric assay for cellular growth and 

survival: application to proliferation and cytotoxicity assays, J lmmunol 

Methods, 65:55-63; 

Muzzarelli R, Baldassarre V, Conti F, Ferrara P, Biagini G, Gazzanelli G, et 

ai. 1988, Biological activity of chitosan: ultrastructural study, Biomaterials, 

9:247-52; 

Muzzarelli RAA. 1997, Human enzymatic activities related to the 

therapeutic administration of chitin derivatives, Cell Moi Life Sei, 53:131-

140; 

Muzzarelli RA, Biagini G, Bellardini M, Simonelli L, Castaldini C, Fratto G. 

1 993, Osteoconduction exerted by methylpyrrolidinone chitosan used in 

dental surgery, Biomaterials, 1 4:39-43; 

Sarasam A, Madihally SV. 2005, Characterization of chitosan-

polycaprolactone blends for tissue engineering applications, Biomaterials, 

26:5500-5508; 

Synowiecki J, AI-Khateeb N A.2003, Production, properties, and some new 

applications of chitin and its derivatives, Crit Rev Food Sei Nutr, 43:145-

171; 

Ueno H, Yamada H, Tanaka I, Kaba N, Matsuura M, Okumura M, 

Kadosawa T, Fujinaga T. 1999, Accelerating effects of chitosan for healing 

at early phase of experimental open wound in dogs, Biomaterials, 20:1407-

1414; 

55 



Yamane S, lwasaki N, Majima T, Funakoshi T, Masuko T, Harada K, 

Minami A, Monde K, Nishimura S-1. 2005, Feasibility of chitosan-based 

hyaluronic acid hybrid biomaterial for a novel scaffold in cartilage tissue 

engineering, Biomaterials, 26:611-619; 

7 FIGURE LEGENDS 

Figure 1. lndirect Cytotoxicity Test for Chitosan Membranes. 

Figure 2. Direct Cytotoxicity Test for Chitosan Membranes. 

Figure 3. Morphology of Vero cells cultured on different chitosan 

membranes, obtained by light microscopy. 

A) Negative contrai for cytotoxicity (CT-); 

B) Positive contrai for cytotoxicity (CT +); 

C) Chitosan membrane (CA); 

D) chitosan plasticized membrane (CP); 

E) chitosan neutralized membrane (CN). Ali assays were performed for 48, 

120 and 240hs of cultured. 

Figure 4. Morphology of Vero cells cultured on different chitosan 

membranes, obtained by scanning electron microscopy. A) Chitosan 

membrane (CA); 8) chitosan plasticized membrane (CP); C) chitosan 

neutralized membrane (CN). 

56 



Contrai-

Contrai -

Figure 1 

lndiret cytotoxicity evaluation 

Contrai+ Chitosan mem brane Chitosan plastidzed Chitosan neutralizecl 

Samples studied 

Figure 2 

Direct cytotoxicity evaluation 

Contrai+ Chitosan membrane Chitosan plasticized Chitosan neutralized 

Samples studied 

57 



Figure 3 

48h 120h 240h 

CT~ 

CT+ 

CA 

CP 

CN 

58 



Figure 4 

59 



4.5 Crystallinity versus Water Vapor Permeability of Chitosan 
Membranes for Wound Dressing 

Publicado nos anais da Advances in Materiais and Processing Technology 
(AMPT) Conference, 2006. 

Cristalinidade versus Permeabilidade ao Vapor D'água de Membranas 

de Quitosana para recobrimento de feridas 

Maria Gabriela Nogueira Campos •:, Carlos Raimundo Ferreira Grosso b 

and Lucia Helena lnnocentini-Mei a 

a Universidade Estadual de Campinas, Faculdade de Engenharia Química, Departamento 

de Tecnologia de Polímeros, Cidade Universitária "Zelerino Vaz" Caixa Postal 6066, 

CEP: 13.083-970, Brasil. 

Autor correspondente. Tel.: + 55 19 3521 -3939/Fax: + 55 19 3521-3938. 

b Universidade Estadual de Campinas, Faculdade de Engenharia de Alimentos, Brasil. 

RESUMO 

Os efeitos da cristalinidade na permeabilidade ao vapor de água das 

membranas de quitosana foram avaliados neste presente estudo. D-

sorbitol, um poli-álcool biocompatível, foi usado como plastificante para 

avaliar seu efeito nas propriedades das membranas de quitosana. As 

membranas de quitosana foram morfologicamente caracterizadas por 

microscopia eletrônica de varredura e difractometria de raios-X. As 

propriedades térmicas foram avaliadas por calorimetria diferencial 

exploratória e as propriedades mecânicas, tais como tração e deformação 

na ruptura também foram medidas. As membranas plastificadas 

apresentaram maior permeabilidade ao vapor d'água e deformação ao 

romper, porém menor tração e cristalinidade. Este comportamento pode 

ser atribuído à maior mobilidade das cadeias poliméricas promovida pela 

adição de plastificante. 

PALAVRAS-CHAVE: quitosana, D-sorbitol, barreira ao vapor d'água, 

difractometria de raios- X. 

60 



Crystallinity versus Water Vapor Permeability of Chitosan Membranes 

for Wound Dressing 

Maria Gabriela Nogueira Campos a:, Carlos Raimundo Ferreira Grosso b 

and Lucia Helena lnnocentini-Mei a 

a State University of Campinas, Faculty of Chemical Engineering, 

Oepartment of Polymer Technology, Cidade Universitária "Zeferino Vaz" 

P.O.Box 6066, Zip code: 13.083-970, Brazil. • Corresponding author. Tel.: 

+55 19 3521-3939/Fax: + 55 19 3521-3938 

Email: gabi@feg.unicamp.br 

b State University of Campinas, Faculty of Food Engineering, Cidade 

Universitária "Zeferino Vaz" Rua Monteiro Lobato, 80 P.O.Box 6121, Zip 

code:13.083-862, Brazil. 

ABSTRACT 

Effects of crystallinity on water vapor permeability of chitosan membranes 

were evaluated in this present study. 0-sorbitol, a biocompatible poly-

alcohol, was used as plasticizer to evaluate its effects on chitosan 

membranes' properties. Chitosan membranes were morphologically 

characterized by Scanning Electron Microscopy and X-Ray Oiffraction 

analyses. Thermal properties were evaluated by Oifferential Scanning 

Calorimetry and mechanical properties, such as tensile strength and 

elongation at break, were also measured. Plasticized membranes showed 

higher water vapor permeability and elongation at break, but lower tensile 

strength and crystallinity. This behavior can be attributed to the higher 

mobility of polymer chains promoted by plasticizer addition. 

KEYWORDS: Chitosan, 0-sorbitol, water vapor barrier, X-ray 

diffractometry. 

INTRODUTION 

Chitosan is a polysaccharide derived from chitin that is the second most 

abundant polysaccharide found in nature. Chitin is largely found in externai 

skeleton of insets and in shell of crustaceans. Chitosan is mainly obtained 

61 



by deacetylation of chitin but it can also be found in lhe cell wall of some 

fungi, such as Mucor rouxii [1). Both chitin and chitosan have been widely 

studied because of their interesting biological properties. 

Chitosan interesting properties include biocompatibility, biodegradability, 

bacteriostatic effect, hemostatic and antitumoral activities, besides promete 

wound healing [2,3). Oue to its unique properties, chitosan has found wide 

application in biomedical area, such as: implants, drug delivery matrix, 

scaffolds for tissue engineering, skin substitutes and wound dressings [4,5 

and 6). 

Chitosan is soluble in acetic acid solution and can easily form films and 

membranes by solvent evaporation technique. However, depending on 

desired properties, plasticizer can be added to 1mprove flexibility and 

plasticity of membranes [7). Polyols, such as sorbitol and glycerol, 

plasticize effectively due to their ability to reduce internai hydrogen bonds 

while increasing intermolecular space [8). 

0-sorbitol is naturally found in berries and fruits and is synthetically 

prepared by high-pressure catalytic hydrogenation of glucose. Besides, 

sorbitol is also produced by lhe human body. Oue to its low toxicity and 

consequently high biocompatibility, 0-sorbitol was used as plasticizer in 

this study. 

Crystallinity probably is the major physical characteristic that determines 

the functional properties of polymers. lt plays an important role in 

adsorption efficiency and swelling behavior [9). Besides, mechanical, 

thermal and barrier properties are also affected by crystallinity. Therefore, 

lhe goals of this present study were to evaluate lhe effectiveness of 0-

sorbitol as plasticizer, as well as to investigate lhe effects of plasticizer 

addition on chitosan membranes' crystallinity, and hence, on their thermal, 

mechanical and barrier properties. 

62 



EXPERIMENTAL 

Materiais 

High molecular weight chitosan (Mw - 1 00,000), more than 75% 

deacetylated, and 0-sorbitol were purchased from Aldrich Chemical 

Company (USA). Glacial acetic acid was purchased from Synth (Brazil). 

Preparation of Membranas 

Chitosan membranes were prepared by solvent evaporation technique by 

using acetic acid (1.0 % w/w) as solvent. Chitosan solution was prepared 

by dissolving 1.5g of chitosan in 100 ml of solvent. After total dissolution, it 

was filtered to remove impurities. 

Chitosan membrane (CA) was obtained by casting the chitosan solution in 

a Petri dish and drying in an oven at 40º C. Neutralized chitosan 

membrane (CN) was prepared by immersing CA into NaOH (2% w/w)-

Na2Co3 (0.05% w/w) aqueous solution for 1 hour. After immersion, CN was 

repeatedly washed with distillated water and dried at 40 o C. 

1.0g of 0-sorbitol was added to chitosan solution in order to prepare the 

plasticized membrane (CP), which was obtained by casting the plasticized 

solution in a Petri dish and drying at 40º C. 

Differential Scanning Ca/orimetry (DSC) 

OSC analyses were performed on a OSC 2920 -TA lnstruments. OSC 

curves of chitosan membranes were obtained by heating samples from -

130 'C up to 200 o C, at heating rate 2 o C min·1 and modulation rate ±1 o C 

min·1 , under nitrogen atmosphere, in order to estimate glass transition and 

melting temperatures. 

X-Ray Diffractometry 

X-ray diffraction of chitosan membranes was performed in a Powder 

Oiffractometer HZG/4A (Freiberger Preazisionsmechanik, Freiberg, 

Germany). The relative intensity was recorded in the scattering range (29) 

of 4 to 40º. 

63 



Scanning Electron Microscopy (SEM) 

Chitosan membranes samples were cut and kept in vacuum desiccators 

for 48 hours. Then, samples were coated with gold/palladium using a SC 

7620 Sputter Coater - POLARON under high vacuum and 4 mA for 180 

seconds. Coated samples were examined using a LEO 440i Scanning 

Electron Microscopic. 

Water Vapor Permeability (WVP) 

WVP of chitosan membranes was measured according to ASTM 96-00 

[1 O] by the Desiccant method. Chitosan membranes were sealed to the 

open mouth of a test dish containing anhydrous calcium chloride, and the 

assembly was placed in a desiccators with controlled atmosphere (75 ± 2% 

RH) at room temperature. The dish assembly was daily weighted and the 

water vapor transmission rate was calculated. Tests were carried out in 

triplicates. 

Mechanical Properties 

Electronic Digital Caliper (Fowler &amp;amp; NSK - Max-Cal) was used to measure 

membranes thickness and TA-XT2 (SMS, Surrey, UK) lnstrument was 

used to measure tensile strength (TS) and elongation at break (E). Tests 

were carried out according to ASTM D-882 [11], with initial grip separation 

of 30 mm forCA and CN and 50 mm for CP. Cross head speed was fixed 

in 1 mm/s in ali tests. 

RESUL TS ANO DISCUSSION 

Differential Scanning Calorimetry and X-ray Diffractometry 

According to Table 1, CA showed higher melting fusion enthalpy that 

indicates higher crystallinity. These results were confirmed by X-ray 

Diffraction analysis (Figure 1 ), in which CA showed strong reflection at 29 

around 10-12º and 18-20º, besides a small peak around 16º that has been 

attributed to the anhydrous crystallattice [12]. 

Moreover, CA showed lower glass transition temperature when compared 

to CN, which can be attributed to the residual acetic acid present in CA that 

acts as plasticizer (13]. Thus, neutralization process removed residual 

64 



acetic acid from CN and promoted a molecular rearrangement that was 

responsible for decreasing the free volume around the polymer chains. 

Therefore, CN showed higher glass transition temperature and lower 

melting one. 

Besides, according to Figure 1, CN showed small peak around 1 0-12Q and 

reflection at 28 around 20-22Q, as observed by Srinivasa et a/[14), which 

indicates some crystallinity. 

Table 1. Thermal Properties of chitosan membranes. 

Sample Tg1 {"C) Tg2{"C) Tg3{ "C) Tm("C) 8H{J/g) 
CA -81.70 -84.1 o -73.69 101.95 458.70 
CN -76.90 -75.63 -73.16 88.39 418.50 
CP -87.51 -85.65 -74.02 102.70 76.82 

As expected, CP showed the most amorphous behavior that can be 

attributed to the plasticizer addition. 

Arvanitoyannis et ai [15] observed low values of fusion enthalpy and glass 

transition temperatures in chitosan and gelatin edible films when different 

amounts of sorbitol were added. 

CP showed lower fusion enthalpy and glass transition temperature and this 

amorphous behavior was confirmed by X-ray diffractometry, since CP did 

not show any strong reflection around 28. 

Scanning Electron Microscopy 

Although thermal and x-ray analyses showed considerable differences 

among CA, CN and CP, no significant structural changes among samples 

was observed by SEM analysis (Figure 2). Ali samples were dense and 

package membranes. Nevertheless, CN showed some superficial rugosity, 

which can be attributed to neutralization treatment. 

65 



4 10 16 22 28 34 40 

Position (2 Theta) 

Figure 1. X-ray Diffractometry of chitosan membranes. 

Water Vapor Permeability and Mechanical Properties 

Plasticizers are theorized to decrease the intermolecular forces along 

polymer chains, increasing flexibility while decreasing the barrier properties 

of films. Thus, as expected, D-sorbitol addition increased WVP and 

elongation at break of CP by decreasing its crystallinity and hence 

increasing the mobility of the polymer chains. On the other hand, CP 

showed lower tensile strength when compared to CA and CN that can be 

explained by its lower degree of crystallinity and glass transition 

temperature. 

Table 2. Barrier and Mechanical Properties of chitosan membranes. 

Sample Thickness{mm) WVP{g*mm/m2*dKPa) TS {MPa) E{%) 

CA 0.0436 ± 0.0028 5.07 ± 0.32 
58.62 ± 18.85 ± 

1.87 2.43 

CN 0.0704 ± 0.0043 5.74 ± 0.05 
79.83 ± 

8.30 ± 2.14 
4.49 

CP 0.0718 ± 0.0089 6.67 ± 0.60 
14.70 ± 83.12 ± 

0.15 1.66 

66 



According to T able 2, CA showed lower WVP due to its higher density of 

crystals that obstructs lhe penetrant's (water vapor) diffusion. In addition, 

CN showed the highest tensile strength and the lowest elongation at break. 

This mechanical behavior can be attributed to the neutralization process 

that promoted a molecular rearrangement in CN, increasing its glass 

transition temperature by decreasing the free volume around the polymer 

chains. 

Figure 2. Micrographs of chitosan membranes. 

CONCLUSIONS 

Plasticizer addition to CP decreased its crystallinity by reducing internai 

hydrogen bonds (intermolecular forces) while increasing the free volume 

around the polymer chains. Moreover, D-sorbitol addition improved WVP 

and flexibility of chitosan membranes that are very important skills for 

wound dressing. 

Although tensile strength had been decreased by plasticizer addition, it still 

can be considerate for wound dressing, since an average tensile strength 

of 17.6 MPA for normal skin was quoted by Wohlish [16]. Moreover, the 

tensile strength of wounds is lower than the skin one and it also varies 

during the wound healing process [17]. 

67 



Finally, 0-sorbitol was effective as plasticizer but future studies must be 

done to evaluate its stability in chitosan membranes. 

ACKNOWLEDGENTS 

The authors thank CNPq and CAPES for financiai support. 

REFERENCES 

[1] Mi, F.L., Shyu, S.S., Wu, Y.B., Lee, S.T., Shyong, J.Y.and Huang, R.N. 

(2001 ). Fabrication and characterization of a sponge-like asymmetric 

chitosan membrane as a wound dressing, Biomaterials, 22: 165-173. 

[2] Kurita, K. (1998). Chemistry and Application of chitin and chitosan, 

Polymer Degradation and Stability, 59: 117-120. 

[3] Berger, J., Reist, M., Mayer, J.M., Felt, 0., Peppas, N.A. and Gurny, R. 

(2004). Structure and lnteractions in covalently and ionically crosslinked 

chitosan hydrogels for biomedical applications, European Journal of 

Pharmaceutics and Biopharmaceutics, 57:19-34. 

[4) Hoemann, C.D., Sun, J., Legare, A., McKee, M.D. and Buschmann, 

M.D. (2005). Tissue engineering of cartilage using an injectable and 

adhesive chitosan-based cell-delivery vehicle, Osteoarthritis Cartilage, 13: 

318-329. 

[5] Denkbas, E.B., Ozturk, E.,Ozdemir, N.,Kececi, K. and Agalar, C. 

(2004).Norfloxacin-loaded chitosan sponges as wound dressing material, 

Journal of Biomaterials Applications, 18(4):291-303. 

[6] Ueno, H., Mo ri, T. and Fujinaga, T. (2001 ). Topical formulations and 

wound healing applications of chitosan, Advanced Drug Delivery Review, 

52(2): 105-115. 

[7] Suyatma, N.E., Tighzert, T., Copinet, A. and Coma, V. (2005). Effects of 

Hydrophilic Plasticizers on Mechanical, Thermal, and Surface Properties of 

Chitosan Films, Journal of Agricultura! and Food Chemistry, 53: 3950-

3957. 

68 



[8] MacHugh, T.H. and Krochta, J.M. (1994). Sorbitol- vs glycerol-

plasticized whey protein edible films: lntegrated oxygen permeability and 

tensile property evaluation, Journal of Agricultura! and Food Chemistry, 42: 

841-845. 

[9] Trung, T.S., Thein-Han, W.W., Qui, N.T., Ng, C.H. and Stevens, 

W.F.(2006) Functional characteristics of shrimp chitosan and its 

membranes as affected by the degree of deacetylation, Bioresource 

Technology, 97: 659-663. 

[1 O] ASTM- Standard Test Methods for Water Vapor Transmission of 

Materiais, Annual Book of ASTM Standards, American Society for Testing 

and Materiais, E 96-00 (2000). 

[11] ASTM - Tensile properties of thin plastics sheeting. Annual Book of 

ASTM Standards, American Society for Testing and Materiais, D 882 

(1995). 

[12] Ogawa,K. (1991 ). Effect of heating an aqueous suspension of chitosan 

on the crystallinity and polymorphs, Agricultura! and biological chemistry, 

55:2375-2379. 

[13] Campos, M.G.N., Grosso, C.R.F., Cárdenas, G. and Mei, L.H.I. 

(2005). Effects of neutralization process on preparation and 

characterization of chitosan membranes for wound dressing, 

Macromolecular Symposia, 229: 253-257. 

[14] Srinivasa, P.C., Ramesh, M.N., Kumar, K.R. and Tharanathan, R.N. 

(2004 ). Properties of chitosan films prepared under different drying 

conditions, Journal of Food Engineering, 63: 79-85. 

[15] Arvanitoyannis, I.S., Nakayama, A. and Aiba, S. (1998) Chitosan and 

gelatin based edible films: state diagrams, mechanical and permeation 

properties, Carbohydrate Polymer, 37: 371-382. 

[16] Wollisch, E. and Kolloid-Z (1943). Vol.14, pg.1 04. 

[17] Elden, H.L. (1971 ). Biophysical Properties of the Skin, John Wiley &amp;amp; 

Sons, Vol. 13 pg. 453. 

69 



4.6 In Vitro Gentamicin Sustained and Controlled Relesse from 
Chitosan Cross Linked Films 

Submetido à revista Carbohydrate Polymers - manuscript number: 

CARBPOL-D-07-00347. 

Liberação sustentada e controlada in vitro de gentamicina a partir de 

filmes reticulados de quitosana 

Campos, M.G.NY, Rawls, H.R. 1, Mei, L.H.I. 2 and Satsangi, N. 1 

1 Divisão de Biomateriais, Escola de Odontologia, Centro de Saúde da Universidade do 

Texas em San Antonio, TX, EUA 

2 Departamento de Tecnologia de Polímeros, Faculdade de Engenharia Química, 

Universidade Estadual de Campinas, SP, Brasil 

RESUMO: A gentamicina é um antibiótico pertencente à família dos amino-

glicosídeos usada no tratamento de infecções causadas por vários tipos 

diferentes de bactéria, particularmente as infecções por bactérias Gram-

negativas. As preparações tópicas de gentamicina são usadas no tratamento de 

infecções de pele; entretanto, elas devem ser aplicadas à área infectada pelo 

menos 3 vezes ao dia. Neste trabalho, um novo recobrimento de ferida foi 

estudado para liberar gentamicina enquanto cobre e protege a ferida, reduzindo a 

dosagem e o número de doses do antibiótico. A quitosana, um biopolímero 

biocompatível e biodegradável, com atrativas características biológicas, foi 

utilizada na preparação dos filmes carregados com antibiótico. O hexametileno 

1 ,6-Di(aminocarboxisulfonato), um diisocianato bloqueado solúvel em água, foi 

usado como agente reticulante e o ácido acético diluído como solvente. O ácido 

acético residual foi neutralizado em uma solução NaOH-Na2C03 e os efeitos do 

tempo de neutralização foram investigados. Além disso, a liberação controlada de 

gentamicina in vitro foi observada por duas semanas e os efeitos da 

concentração inicial deste antibiótico, do grau de reticulação da quitosana e do 

tempo de neutralização das membranas na cinética de liberação da gentamicina 

foram avaliados. 

PALAVRAS-CHAVE: gentamicina, quitosana, recobrimento de feridas, 

reticulação, liberação sustentada e controlada. 

70 



In vitro Gentamicin Sustained and Controlled Release 

From Chitosan cross linked Films 

M. G. N. Campos 1' 2 , Ralph H. Rawls 1 , L. H. I. Mei2 , Neera Satsangi 1 

1 
Department of Restorative Dentistry, Biomaterials Division, Dental 

School, University of Texas Health Science Center at San Antonio, TX, 

USA 

2 Department of Polymer Technology, Faculty of Chemical Engineering, 

State University of Campinas, SP, Brazil 

Abstract 

Gentamicin, an amino-glycoside antibiotic used to treat infections caused 

by many types of bacteria, is used topically to treat skin infection; however, 

these formulations should be applied to affected area at least three times a 

day with mandatory cleaning at each application. In this work, a novel 

wound dressing film was investigated for controlled and sustained delivery 

of gentamicin while covering and protecting the wound. Chitosan, a 

biocompatible and biodegradable biopolymer with attractive wound healing 

properties, was crosslinked with Hexamethylene 1 ,6-

Di(aminocarboxysulfonate) to contrai the retention and release of 

encapsulated gentamicin from the formulated film. In vitro gentamicin 

release from the above antibiotics loaded films in phosphate buffered 

saline at physiological pH and temperatura was studied for 2 weeks. The 

effects of gentamicin initial concentration, and cross-linking ratio on the 

kinetics of gentamicin release were evaluated. 

Keywords: gentamicin, chitosan, wound dressing film, cross-linking, 

controlled and sustained drug release. 

1. lntroduction 

Gentamicin is one of the most consumed antibiotics because of its low 

cost, broad antibacterial spectrum of action, low rate of primarily resistant 

pathogens, low allergy rate, good stability and water solubility (Virto, 

Frutos, Torrado, &amp;amp; Frutos, 2003). Gentamicin binds to components in the 

71 



bacterial cell and causes the production of abnormal proteins; the 

production of these abnormal proteins is ultimately fatal to the bacteria. 

Gentamicin can treat many types of bacterial infections, particularly Gram-

negative infection; it eliminates bacteria that cause infections in lung, skin, 

bone, joint, stomach, blood, and the urinary tract infections. However, it is 

not absorbed from the gut and is consequently only given by injection or 

infusion. 

Gentamicin topical preparations are used to treat the infections of skin. 

Topical preparations are available in two dosage forms: cream and 

ointment. Skin wound treatment with topical gentamicin includes three 

basic steps: 1- washing the affected area with water and soap; 2-

application of a small amount of the cream or ointment to the affected area 

and, finally, 3- covering the treated area with a gauze dressing. This 

procedure should be repeated at least three times a day, or in accordance 

with a physician's prescription. Thus, traditional gentamicin topical 

treatment is painstaking, besides which it can lead to failure in infection 

control or delay in wound healing, since the dosage is imprecise and 

delivered discontinuously. For these reasons, a novel antibiotic-releasing 

wound dressing was investigated in lhe present work. 

As most of the common polymers are synthetic, their biocompatibility and 

biodegradability are quite limited compared to the natural polymers such as 

cellulose, chitin, chitosan and their derivatives. However, many naturally 

abundant polymeric materiais also exhibit a limitation in their reactivity, 

biodegradability and processability (Mass, Mass, &amp;amp; Tighe, 1998; lllum, 

1998), but chitosan is recommended as suitable functional material, 

because of its excellent biocompatibility, biodegradability, non-toxicity, and 

adsorption properties, etc. In addition, chitosan can accelerate wound 

healing and has shown hemostatic and bacteriostatic activities (Mass, 

Mass, &amp;amp; Tighe, 1998; Berger, 2004). The source of chitosan is chitin, the 

natural waste derived from the discarded shells of crab and shrimp etc. 

and the second most abundant polysaccharide. Chitosan finds wide 

applications such as implants, drug delivery matrix, scaffolds for tissue 

72 



engineering, skin substitutes and wound dressings (Hoemann, 2005; 

Denkbas, 2004; Ueno, Mo ri, &amp;amp; Fujinaga, 2001 ). In bio-delivery applications, 

chitosan has been used as a vehicle for drug, protein and gene delivery 

(Chen, Wu, Mi, Lin, YU, &amp;amp; Sung, 2004; Yuan, Chesnutt, Utturkar, Haggard, 

Yang, Ong, &amp;amp; Bumgardner, 2007; Sinha Singla, Wadhawan, Kaushik, 

Kumria, &amp;amp; Bansal, 2004). 

Chitosan is soluble in acid solutions and can easily form films and 

membranes by solvent evaporation. However, due to its positive charge in 

acid medium, caused by amino group protonation, it becomes extremely 

hygroscopic hydrogel; the retention and lhe release of a biomolecule 

depends on the swelling/deswelling of hydrogel, which may vary by severa! 

factors including the amount of water in hydrogel. To increase the time 

trame and consistency of kinetics of drug delivery, hydrophilic polymers 

need to be cross-linked (Jameela, Kumary, Lal, &amp;amp; Jayakrishnan, 1998). 

Severa! methods are available for the cross-linking of chitosan, the most 

common being the one using glutaraldehyde as lhe cross-linker (Hirano, 

Yamaguchi, Matsuda, Miura, &amp;amp; Kondo, 1977). However, there are 

concerns over lhe toxicity of the cross-linking agents used, especially the 

glutaraldehyde, the residual retention of which may compromise the 

biocompatibility of chitosan delivery system. 

Recently, a novel water-soluble, bisulfite blocked diisocyanate has been 

prepared and used as a cross-linking agent for lhe network formation of 

chitosan gel (Welsh, Schauer, Qadri, &amp;amp; Price, 2002; Lin-Gibson, Walls, 

Kennedy, &amp;amp; Welsh, 2003). In fact, the bisulfite blocked diisocyanate is the 

analogous Di-aminocarboxysulfonate, which must be devoid of any toxic 

effects of the relative diisocyanate. Also, the bisulfite derivatization of a 

diisocyanate group makes the blocked crosslinker soluble in water to allow 

for easy processability of crosslinked chitosan gel formations. Thus, 1 ,6-

Hexamethylene dilsocyante (HMDI), a well studied diisocyanate was 

selected as cross-linking agent and reacted with sodium bisulfite to 

prepare the analogous blocked diisocyanate: Hexamethylene 1 ,6-Di-

(aminocarboxysulfonate) (HDACS; Fig. 1 ). 

73 



o H 
l'•uro SJlN~Nf(SOã Na+ 

3 H O 

Fig. 1: Structure of Hexamethylene 1,6-
Di(aminocarboxysulfonate) 

Therefore, this research designs a chitosan formulation, crosslinked 

through the aforesaid water soluble blocked diisocyante crosslinker, and 

loaded with gentamicin in a mild acidic solution and eventually casted into 

a film, for sustained and consistent delivery of the antibiotic. The residual 

acid was neutralized with NaOH-Na2C03 aqueous solution for varied time 

lengths. The resultant biomaterial was characterized for crosslinkage by 

FTIR, for hydrophilicity and swelling behavior and for the in vitro 

gentamicin controlled release over an extended period of 2 weeks; the 

effects of gentamicin initial concentration, cross-linking ratio and 

neutralization time on the kinetics of gentamicin release were also 

evaluated. 

2. Experimental 

2. 1 Materiais and lnstrumentation 

High molecular weight chitosan (Mw -100,000, &gt;75% deacetylated), 

Acetone, acetic acid, sodium bisulfite, ninhydrin, sodium hydroxide, sodium 

carbonate and hexamethylene diisocyanate (HMDI) were purchased from 

Aldrich Chemical Co., Milwauki, Wisconsin. Gentamicin sulfate and 

phosphate buffered saline (PBS) were purchased from Sigma Chemical 

Co. St. Louis, MO. 

FTIR analyses were performed on a MIDAC - M series FTIR instrument 

from MIDAC Corporation (Costa Mesa, California); Contact angle 

instrument (Model: VCA-2000) was obtained from AST Products, Billerica, 

MA. 

2.2 Synthesis of Hexamethylene 1,6-0i(aminocarboxysu/fonate) 

In a 100 ml round-bottom flask containing a magnetic stir bar, 6.73 g (40 

mmol) of HMDI was added to 8.36 g Na2S20s (44 mmol) dissolved in 15.53 

74 



ml H20 and stirred for 20h. The product was precipitated with acetone 

and dried in vacuum. lnsoluble polymeric byproducts were removed by 

dissolving the product in water (30 ml) followed by filtration. Product was 

isolated from the filtrate by precipitation in acetone and dried in vacuum, 

resulting in a white powder, as described earlier (Lin-Gibson, Walls, 

Kennedy, &amp;amp; Welsh, 2003). 

2.3 Experimental Design for in-vitro gentamicin release from crosslinked 

chitosan 

The effects of cross-linking ratio (0, 30 and 50%), initial antibiotic 

concentration (0, 1 and 1 0%) and neutralization time (0, 30 and 60 

minutes) on lhe kinetics of in vitro release of gentamicin were investigated 

in a 3x3 factorial design (Table-1). The drug release was followed for 2 

weeks and a colorimetric procedure, based on the ninhydrin reaction with 

amines present in gentamicin, was employed for released gentamicin 

quantification. 

Table 1 -Experimental Design. 

Sample# Concentration of Concentration of Neutralization time, 

HDACS,%* Gentamicin Sulfate, %** (min.) 

1 o o o 

2 o 1 30 

3 o 10 60 

4 30 o 30 

5 30 1 60 

6 30 10 o 

7 50 o 60 

8 50 1 o 

9 50 10 30 

*based on NH2 availability on chitosan; **based on chitosan concentration. 

This outline uses the Taguchi "robust" statistical design in which the main 

effects are identified. 

75 



2.4 Cross-linking reaction 

Crosslinking was performed by a modification in the procedure as 

described earlier (Lin-Gibson, Walls, Kennedy, &amp;amp; Welsh, 2003). Briefly, in a 

250 ml flask, 1.5g of chitosan was dissolved in 100 ml of 1.0% aq. acetic 

acid with vigorous stirring. After total dissolution, the desired amount of 

Hexamethylene 1 ,6-Di(aminocarboxysulfonate) was added and the 

solution was heated to 60 "C under stirring for 24 h. 

2.5 Preparation of gentamicin loaded films 

After cross linking reaction, the desired amount of gentamicin sulfate was 

added to the solution and stirred for 24 h. One ml of the resultant solution 

was placed in each of the circular plastic molds of 16 mm diameter. The 

contents in the molds were allowed to dry at roam temperature to form the 

circular films. The dried samples were then treated with aqueous NaOH 

(2.0% w/w)-Na2C03 (0.05% w/w) solution to remove residual acetic acid. 

The time for alkaline treatment was chosen for different samples according 

to schedule shown in Table-1 above. 

2.6 FTIR analyses 

FTIR analyses on above thin film samples were performed on a MIDAC -

M series FTIR instrument. The samples were scanned in the range of 500 

to 2000 cm·1 . 

2.7 Contact Angle 

The experiments for contact angle measurements were performed in arder 

to evaluate water affinity (hydrophilicity), an important parameter for wound 

dressings. The water contact angle with chitosan films was obtained by 

carefully placing a drop of water on the film surface and then, after 30 

seconds, both right and left angles of contact were measured by the 

contact angle instrument, using a reported method (Zhang, 

Radomyselskiy, Datta, Zhao, &amp;amp; van Ooij, 2003). 

76 



2.8 Swelling Behavior 

Swelling behavior of the above films was assessed by the gravimetric 

method. Samples films were kept in a vacuum desiccator for 24 h before 

determining dry mass (mO) by weighing to +1-0.0001 g places on an 

electronic balance. Then, the samples were immersed for 24 h in 0.1 M 

PBS maintained at pH 7.4 at 37"C. The soaked samples were then blotted 

with filter paper to remove non-absorbed surface water and then weighed 

again to determine wet mass (mW). Swelling ratio (S) was calculated, 

using the following equation: 

S (%) = [(mw- mo)/mw] X 100 

Reported values are averages of three samples. 

2. 9 In vitro release 

Experiments on In vitro release of gentamicin from the above chitosan 

films were performed at 37"C in 0.1 M PBS, pH 7.4. The release medium 

was collected after each 24 h and replaced with fresh buffer each time. 

This procedure was repeated for 14 days and the experiment was carried 

out in triplicate. Gentamicin concentration was measured indirectly by 

reaction with ninhydrin for 15 minutes at 95 "C, followed by determination of 

ultraviolet absorbance at 400 nm by an established method (Frutos, 

Torrado, Perez-Lorenzo, &amp;amp; Frutos, 2000). 

3. Results and discussion 

Topical formulations of chitosan for wound healing and related applications 

and their effects on wound related components are being intensely 

investigated (Ueno, Mo ri, &amp;amp; Fujinaga, 2001 ). The use of chitosan for the 

controlled delivery of biomolecules is on rise recently (Yuan, Chesnutt, 

Utturkar, Haggard, Yang, Ong, &amp;amp; Bumgardner, 2007; Sinha, Singla, 

Wadhawan, Kaushik, Kumria, &amp;amp; Bansal, 2004). But, it forms extremely 

hygroscopic hydrogels and the controlled retention and release of a 

biomolecule from chitosan could be achieved by an appropriate 

77 



biocompatible cross-linker that has physicochemical compatiobility with 

chitosan. This work evaluates such a crosslinked chitosan based controlled 

release device to be later used for wound dressing film for sustained 

gentamicin release. 

3. 1 Cross-Jinker and cross-/inking 

To attain lhe crosslinking, first HDACS was synthesized as a crosslinker by 

a known method; it was then incorporated in required amounts (Table-1) in 

acidic solution of chitosan and the crosslinking, by the formation of urea 

linkage between HDACS and preferably the amino group of chitosan, was 

realized by mild heating for 24 h. Apparently, crosslinking must affect lhe 

hydrophilic behaviors of lhe crosslinked chitosan film, therefore after 

neutralization of residual acid, lhe water-contact angles and swelling 

behavior of the resultant films were measured. However, confirmation of 

chitosan crosslinking with HDACS was dane by FTIR. The examination of 

lhe Hexamethylene 1 ,6-Diurea crosslinked chitosan films through various 

parameters used in this work is described as follows: 

3.1.1 FTIR 

The development of cross-linking was shown by a well resolved peak 

between 1565 cm-1 and 1475 cm-1, characteristic of NH deformation in 

secondary amides (Amide 11 band). In addition, a peak at about 1600 cm-1, 

representing C=O stretch in secondary amides (Amide I band), was only 

observed for cross linked films, and its resolution was greater for the 50% 

cross linked samples (Welsh, Schauer, Qadri, &amp;amp; Price, 2002). 

3. 1.2 Contact angle measurement 

The results obtained for lhe non-cross linked chitosan film were Right: 

85.7° and Left: 85.2°. However, for both cross linked films (30% and 50% 

cross linked), the contact angles were 0°, since the water drop spread on 

the films. Thus, cross-linking increased the hydrophilic character of 

chitosan films. 

3. 1.3 Swelling behavior 

78 



The swelling behavior of chitosan films is presented in Figure 2. As 

expected, cross-linking suppressed swelling. However, this effect was 

inversely proportional to lhe degree of cross-linking, which can be 

attributed to the hydrophilic character of lhe cross linking agent. 

Swelling Behavior 
100 

90 
80 
70 

~ 60 
~ 
~ 50 
rJ) 40 

30 
20 
10 
o 

O% cross linked 30% cross linked 50% cross linked 
chitosan chitosan chitosan 

Samples 

Figure 2 - Swelling behavior of Chitosan and HDACS cross-linked 

samples. 

3.2 In vitro gentamicin re/ease study 

Results of in vitro release of gentamicin are presented in Figure 3. 

Samples 1, 4 and 7 were not plotted because !hei r gentamicin initial 

concentration was O (Table 1 ). 

79 



Gentamicin Cumulativa Release 
100 --· ----··--··-·-·- ·····-·---·------------- --···-------------- -------

1 

00~---------------------------~~~~~ 
jX-Iink, [Gent], Neut time I 

~ 00~----------------------------------~==~=r----~ 
m i m ~r----------------------------------------
ãi ~ 30,&gt;60 
a: 60 
~ ~ i 
:~50 ~ 
.! 40 
~ 30 ~ 
~20 ~~ 8 ~ 

10 r 9 
ob " 

50,1,0 

-" 30,10,0 

... 0,1,30 

50,10,30 

0,10,60 

o 2 3 4 6 7 8 9 10 11 12 13 14 

Days 

Figure 3- Gentamicin cumulative release. 

Since samples 2 and 3 were not cross linked, a considerable high amount 

of initial release of gentamicin was expected form these samples 

compared to those with crosslinking. However, the contrary effect was 

observed. Because of the good solubility of gentamicin in aqueous 

medium, probably most of gentamicin was released to the neutralization 

media when these samples were neutralized. Thus, after neutralization, the 

initial concentration of gentamicin for in vitro release experiment was lower 

than expected. However, this effect was not observed for cross-linked 

samples, because cross-linking created a polymeric network that might 

have acted as a barrier to fast diffusion of gentamicin during neutralization 

process. 

Comparing sample pairs with the same degree of cross linking and 

different amounts of gentamicin (5 and 6; 8 and 9), it was observed that 

higher gentamicin initial concentration promoted slower percent release 

and the lower gentamicin initial concentration showed higher percent 

release. Therefore, the mechanism of gentamicin diffusion was mainly 

governed by its initial concentration. lndeed, the diffusion rate was 

inversely proportional to gentamicin initial concentration. 

80 



Comparing couples of sample pairs with the same gentamicin initial 

concentration, but different degrees of cross linking (5 and 8; 6 and 9), 

higher cross linking produced slower release. This was of course expected 

as lhe higher cross-link density increases the barrier for gentamicin 

diffusion. Thus, the diffusion rale was inversely proportional to the degree 

of cross-linking. 

Pseudomonas aeruginosa, Escherichia co/i and Staphy/ococcus aureus 

are the mos! common pathogens found in skin infected wounds. Minimal 

inhibition concentration of gentamicin for Pseudomonas aeruginosa and 

Escherichia co/i varies between 0.06 through 8 IJg/mL and for 

Staphylococcus aureus, it is between 0.12-1.0 IJgfuL (Skundrik, Medovic, 

&amp;amp; Kostic, 2002). Therefore, lhe initial concentration of gentamicin should 

be selected according to pathogen in target and also to the treatment 

period. Prolonged treatments require slow diffusion and hence higher 

gentamicin initial concentration; for short treatments, lhe minimal inhibition 

concentration is reached even with lower gentamicin initial concentrations. 

4. Conclusions 

Chitosan - HDACS cross-linking reaction was efficient and confirmed by 

FTIR and hydrophilic behavior analyses. Cross-linked films swell less than 

chitosan film itself; however, this effect was inversely proportional to cross 

linker concentration, due to lhe hydrophilic character of the cross linking 

agent. Moreover, according to contact angle analysis, cross-linked films 

became more hydrophilic than the chitosan film itself. 

In vitro gentamicin controlled release was carried out at 37° C and in pH 

7.4 in arder to simulate the body conditions. Results showed that the 

diffusion rale is governed by initial concentration of gentamicin and degree 

of cross-linking. Higher gentamicin initial concentration and degree of cross 

linking promoted the slower release: after 14 days of release, less than 

20% of gentamicin initial concentration had been delivered (sample 9). On 

the other hand, lower gentamicin initial concentration and degree of cross-

81 

UNlCAV;'? 
BIBliOTECA CENTRAL 

CtSAR LAfTES 

DESENVOLVlMENTO DE COLEÇÁO 



linking promoted lhe faster release, with almost 70% of lhe gentamicin 

initial concentration released after 14 days (sample 5). 

The process of neutralization seems to be limiting for non-crosslinked 

gentamicin loaded chitosan films. In this case, gentamicin initial 

concentration was altered by neutralization, since gentamicin was rapidly 

removed by dissolving into lhe neutralization media. 

Additional experiments on wound healing were carried out with selected 

samples and will be published in communication later. 

Acknowledgements 

The authors are thankful to lhe department o f Restorative Dentistry, 

University of Texas Health Science Center at San Antonio, TX, USA and 

lhe department of Polymer Technology, Faculty of Chemical Engineering, 

State University of Campinas, SP, Brazil for providing necessary facilities 

for this work. 

References 

Berger, J. (2004). Structure and lnteractions in covalently and ionically 

cross linked chitosan hydrogels for biomedical applications. Eur. J. 

Pharmaceut. Biopharmaceut. 57, 19-34. 

Chen, S. C., Wu, Y. C., Mi, F. L., Lin, Y. H., YU, L. C., &amp;amp; Sung, H. W. 

(2004). A novel pH-sensitive hydrogel composed of N,O-carboxymethyl 

chitosan and alginate cross-linked by genipin for protein drug delivery. J. 

Contrai. Rei. 96, 285-300. 

Denkbas, E. (2004). Norfloxacin-loaded Chitosan Sponges as Wound 

Dressing Material. J. Biomat. Appl. 18, 291-303. 

Frutos, P., Torrado, S., Perez-Lorenzo, M. E., &amp;amp; Frutos, G. (2000). A 

validated quantitative colorimetric assay for gentamicin. J. Pharmaceut. 

Biomed. Anal. 21, 1149-1159. 

Hirano, S., Yamaguchi, R., Matsuda, N., Miura, 0., &amp;amp; Kondo, Y. (1977). 

Chitosan-aldehyde gel a novel polysaccharide gel produced from chitosan 

and aldehydes. Agric. Biol. Chem. 41, 1547-1548. 

82 



Hoemann, C. (2005). Tissue engineering of cartilage using an injectable 

and adhesive chitosan-based cell-delivery vehicle. Osteoarthritis 

Cartilage. 13, 318-329. 

lllum, L. (1998). Chitosan and its use as pharmaceutical excipient. Pharm. 

Res. 15, 1326. 

Jameela, S. R., Kumary, T. V., Lal, A. V., &amp;amp; Jayakrishnan, A. (1998). 

Progesterone-loaded chitosan microspheres: a long acting biodegradable 

controlled delivery system. J. Control. Rei. 52, 17-24. 

Kurita, K. (1998). Chemistry and Application of chitin and chitosan. Polym. 

Degradation and Stability. 59,117-120. 

Mass, W. A., Mass, A., &amp;amp; Tighe, 8. (1998). A review of biodegradable 

polymers: uses, current developments in the synthesis and 

characterization of biodegradable polyesters. 81ends of biodegradable 

polymers and recent advances in biodegradation studies, Polym. lnt. 47, 

89. 

Lin-Gibson, S., Walls, H. J., Kennedy S. 8., &amp;amp; Welsh E. R (2003). Reaction 

kinetics and gel properties of blocked diisocyanate cross linked chitosan 

hydrogels. Carbohydrate Polymers 54, 193-199. 

Sinha, V. R., Singla, A. K., Wadhawan, S., Kaushik, R., Kumria, R., &amp;amp; 

8ansal, K. (2004). Chitosan microspheres as a potential carrier for drugs. 

lnternational J. Pharmaceut. 274, 1-33. 

Skundric, P., Medovic A., &amp;amp; Kostic, M. (2002). Fibrous systems with 

programmed biological-activity and their application in medicai practice. 

AUTEX Res. J. 2, 78-84. 

Ueno, H., Mori, T., &amp;amp; Fujinaga, T. (2001 ). Topical formulations and wound 

healing applications of chitosan. Advanced Drug Del. Rev. 52, 105-115. 

Virto, M. R., Frutos, P., Torrado, S. &amp;amp; Frutos, G. (2003). Gentamicin 

release from modified acrylic bone cements with lactose and 

hydroxylpropylmethylcelullose. 8iomaterials. 24, 79-87. 

83 



Welsh, E. R., Schauer, C. L., Qadri, S. 8., &amp;amp; Price, R. R. (2002). Chitosan 

cross-linking with a water-soluble, blocked diisocyinate. 1. Solid state. 

Biomacromolecules. 3, 1370-137 4. 

Yuan, V., Chesnutt, B.M., Utturkar, G., Haggard, W.O., Vang, V., Ong, J.L., 

&amp;amp; Bumgardner, J.D. (2007). The effect of cross-linking of chitosan 

microspheres with genipin on protein release. Carbohydrate Polym. 68, 

561-567. 

Zhang, J., France, P., Radomyselskiy, A., Datta, S., Zhao, J., van Ooij, W. 

J. (2003). Hydrophobic cotton fabric coated by a thin nanoparticulate 

plasma film. J. Appl .Polym. Sei. 88, 1473-1481. 

84 



4.7 In vitro Silver sulfadiazine Controlled Release from Chitosan 
cross linked Films 

Liberação Controlada de Sulfadiazina de Prata In vitro a partir de 

Filmes Reticulados de Quitosana 

Campos, M.G.NY, Rawls, R.H. 1 , Mei, L.H.I. 2 and Satsangi, N. 1 

1 
Departamento de Odontologia Restaurativa, Divisão de Biomateriais Division, Escola de 

Odontologia, Centro de Saúde da Universidade do Texas em San Antonio, TX, EUA 

2 Departamento de Tecnologia de Polímeros, Faculdade de Engenharia Química, 

Universidade Estadual de Campinas, SP, Brasil 

RESUMO: A sulfadiazina de prata é um agente antibacteriano eficiente e 

amplamente utilizado no tratamento de queimaduras, devido ao seu amplo 

espectro de atividade contra bactérias Gram positivas e Gram negativas. A 

pomada de sulfadiazina de prata tem sido usada para tratar feridas de 

queimadura infeccionadas; entretanto, este tratamento é doloroso, 

podendo levar à falha ou ao atraso da cicatrização, além de ter que ser 

repetido pelo menos duas vezes ao dia. Neste trabalho, desenvolveu-se 

um recobrimento de ferida carregado com sulfadiazina de prata , com a 

função de cobrir e proteger a ferida, além de liberar o princípio ativo aol 

longo do tempo, reduzindo a dosagem e o número de doses do do 

mesmo. A quitosana, um biopolímero biocompatível e biodegradável com 

atrativas características biológicas, foi utilizada na preparação dos filmes 

carregados de sulfadiazina de prata. Como agente reticulante, utilizou-se o 

hexametileno 1 ,6-Di(aminocarboxisulfonato), que é um diisocianato 

bloqueado e solúvel em água. A liberação de sulfadiazina de prata in vitro 

foi acompanhada por 2 semanas. Os efeitos da concentração inicial da 

sulfadiazina de prata, do grau de reticulação da matriz polimérica e do 

tempo de neutralização na cinética de liberação da sulfadiazina de prata 

foram avaliados. 

PALAVRAS-CHAVE: sulfadiazina de prata, quitosana, recobrimento de 

feridas, reticulação. 

85 



In vitro Silver sulfadiazine Controlled Release from Chitosan cross 

linked Films 

Campos, M.G.NY, Rawls, R.H.\ Mei, L.H.I. 2 and Satsangi, N. 1 

1 Department of Restorative Dentistry, Biomaterials Division, Dental 

School, University of Texas Health Science Center at San Antonio, TX, 

USA 

2 Department of Polymer Technology, Faculty of Chemical Engineering, 

State University of Campinas, SP, Brazil 

ABSTRACT: Silver sulfadiazine is an effective and widely used 

antibacterial agent for treatment of burn injuries, due to its broad spectrum 

of activity against Gram-negative and Gram-positive bacteria. Silver 

sulfadiazine cream has been used to treat burn wound infections; however, 

this treatment is painstaking, can lead to failure in infection treatment or 

delay in wound healing and should be repeated at least twice a day. In this 

work, a novel wound dressing was developed to controlled delivery silver 

sulfadiazine while covering and protecting the wound, as well, reducing the 

drug dosage and dosing times. Chitosan, a biocompatible and 

biodegradable biopolymer with attractive biological characteristics, was 

used to prepare the antibiotic loaded films. Hexamethylene 1 ,6-

Di(aminocarboxysulfonate), a water soluble and blocked diisocyante, was 

used as cross-linker agent. In vitro sulfadiazine release was observed for 2 

weeks. The effects of silver sulfadiazine initial concentration, cross-linking 

ratio and neutralization time on the kinetics of sulfadiazine release were 

evaluated. 

KEYWORDS: silver sulfadiazine, chitosan, wound dressing, cross-linking. 

INTRODUCTION 

Sulfadiazine (Figure 1) is a sulfonamide antibiotic which eliminates bacteria 

that cause infections by stopping the production of folic acid inside the 

bacterial cell. lt is commonly used in combination with silver to treat skin 

86 



wounds. Silver sulfadiazine has been a standard treatment for burns, 

ulcers and infected wounds due to its broad spectrum of activity against 

both Gram positive and negative bacteria, besides fungus, even at low 

concentration.[1] Silver sulfadiazine cream has been traditionally applied to 

wounds; however, it can not allow long-term protection of lhe wound from 

infection. For this reason, topical silver sulfadiazine should be applied to 

lhe wound at least twice a day, according to doctor prescription. Thus, 

traditional treatment can lead to failure in infection treatment or delay in 

wound healing, since lhe dosage is not precisely and continuous. 

Moreover, absorption of silver ions has been a major concerned during 

usage of silver sulfadiazine cream in deep burns that may be cytotoxic for 

treated tissues. [2] 

Due to ali these reasons, a novel silver sulfadiazine loaded wound 

dressing was developed, in arder to protect the wound, while releases 

antibacterial agent to treat or avoid bacterial infection. 

Chitosan is a biopolymer derived from chitin, the second most abundant 

polysaccharide found in nature. Chitosan has been extensively studied in 

biomaterials field. lt is biocompatible and biodegradable. In addition, 

chitosan can accelerate wound healing and has shown hemostatic and 

bacteriostatic activities.[3,4] Due to its unique properties, chitosan has 

found wide application in biomedical area, such as: implants, drug delivery 

matrix, scaffolds for tissue engineering, skin substitutes and wound 

dressings.[5,6 and 7] 

Chitosan is soluble in acid solutions and can easily form films and 

membranes by solvent evaporation technique. However, due to its positive 

charges in acid medium, caused by its amino group protonation, chitosan 

is extremely hygroscopic. In this way, it is necessary to crosslink its chains, 

in arder to prepare an efficient drug delivery matrix. 

Diisocyanates are usually used as cross-linker agent in Chemical 

lndustries. However, because of reactivity with and insolubility of most 

commercially available diisocyanates in water, it should be reacted with a 

87 



bisulfite to protect, or block, reactivity and to increase water solubility 

before be reacted with chitosan. Thus, the product of block reaction, stable 

in acidic aqueous solutions, with increased pH or temperature, readily 

reacts with amines, forming a urea linkage, at a rate much greater than 

that characteristic of competing reactions with alcohols or water. 

Furthermore, stability in the presence of amines and consequent long-term 

storage may be increased by the choice of an aliphatic diisocyanate, rather 

than a more reactive aromatic one. For this reason, HMDI (1 ,6-

HexaMethylene Dilsocyante), a well studied diisocyanate frequently used 

in the Polyurethane lndustry, was selected as cross-linker agent and hence 

reacted with sodium bisulfite, in order to prepare a blocked diisocyanate: 

Hexamethylene 1 ,6-Di(aminocarboxysulfonate). 

The effects of cross-linking ratio (0, 30 and 50%), silver sulfadiazine initial 

concentration (O, 1 and 1 0%) and neutralization time (0, 30 and 60 

minutes) on the in vitro release of silver sulfadiazine were evaluated. The 

release was followed for 2 weeks and sulfadiazine concentration was 

determined by UV Spectrophotometry. 

Figure 1- Sulfadiazine and silver sulfadiazine structures. 

MATERIALS ANO METHODS 

Materiais 

High molecular weight chitosan (&gt;75% deacetylated), silver sulfadiazine 

and hexamethylene diisocyanate were purchased from Aldrich. Sodium 

bisulfite Reagent Plus® was purchased from Sigma-Aidrich. 

Synthesis of Hexamethylene 1 ,6-Di(aminocarboxysulfonate) 

In a 1 00 ml round-bottom flask containing a magnetic stir bar, 6. 73 g ( 40 

mmol) of HMDI was added to 8.36 g Na2S205 (44 mmol) dissolved in 15.53 

ml H20 and was stirred for 20h at roam temperature. The product was 

88 



precipitated in acetone and dried in vacuum. lnsoluble polymeric 

byproducts were removed by dissolving the product in water (30 ml) 

followed by filtration. Product was isolated from the filtrate by precipitation 

in acetone and dried in vacuum, resulting in a white powder.[S] 

Experimental Design for in vitro controlled release 

Matrix experiments using orthogonal arrays were applied for experiment 

design. Samples were prepared according to Table 1. 

Cross linking reaction 

In a 250 ml flask, 1.5g of chitosan was dissolved in 1.0% acetic acid 

solution. After total dissolution, the desired amount of Hexamethylene 1 ,6-

Di(aminocarboxysulfonate) was added and the solution was heated up to 

40 "C under stirring for 24 h. 

Preparation of si/ver sulfadiazine loaded films 

After cross linking reaction, the desired amount of silver sulfadiazine was 

added to the solution and stirred for 24 h. Then, the resulted solution was 

cast in the molds and dried at roam temperature. Dried samples were then 

neutralized in Ethanol 70% solution according to Table 1. 

Table 1 -Experimental Design. 

Sample Concentration of Hexamethylene lnitial Concentration Neutralization 
1 ,6-Di (aminocarboxysulfonate), of Silver time, min. 
0/o* Sulfadiazine, %** 

1 o o o 
2 o 5 30 
3 o 10 60 
4 30 o 30 
5 30 5 60 
6 30 10 o 
7 50 o 60 
8 50 5 o 
9 50 10 30 

*based on NH2 availability on chitosan; **based on chitosan concentration. 

FTIR 

FTIR analyses were performed in a MIDAC- M series FTIR instrument in 

the range of 500 up to 2000 cm·1 . 

89 



Contact Angle 

Contaet angle measured was performed in an AST model VCA 2000 

instrument, in order to evaluate samples' water affinity (hydrophilieity) that 

is an important parameter for wound dressings. 

Swelling Behavior 

Swelling behavior of ehitosan films was determined by the gravimetrie 

method. Samples (D= 1 em) were kept in a vaeuum desieeators for 24 h 

and then, their dry mass (mD) were determined by weighting them on an 

eleetronie seale. After this proeedure, samples were immersed in 0.1 M 

PBS pH 7.4 at 37"C. Past 24 h, samples were blotted with filter paper to 

remove the adsorbed water on the surfaee, and weighted again in order to 

determine their wet mass (mw). The swelling ratio (S) of chitosan films was 

calculated according to the following Equation: 

S (%) = [(mw- mo)imw] *100 

In vitro release 

In vitro release of sulfadiazine from ehitosan films was performed at 37'C 

in 0.1 M PBS, pH 7.4. The release medi um was collected at predetermined 

time intervals (24 h) and replaced with fresh buffer. This procedure was 

repeated for 14 days and carried out in triplieates. Samples were analyzed 

by UV Spectrophotometer at 236 nm to determine the concentration of 

released sulfadiazine. 

RESULTS 

FTIR 

According to the infra red spectra, cross linking reaction could be 

supported by the presence of a peak better resolved in between 1565 em·1 

and 1475 cm·1, that represents NH deformation in seeondary amides 

(Amide li band). In addition, a peak around 1600 em·\ that represents C=O 

streteh in seeondary amides (Amide I band), was only observed for eross 

linked films, and its resolution was greater for the 50% cross linked 

sample.[9] 

90 



Contact Angle 

The water contact angle with chitosan films was obtained by dropping 1 

drop of water on lhe film surface and then, after 30 seconds, both right and 

left angles of contact were measured. The results obtained for the not 

cross linked chitosan film were R: 85.7° and L: 85.2°. However, for both 

cross linked films (30% and 50% cross linked), the contact angles were o o, 
since the water drop spread on the films. lt means that cross linking 

reaction increased the hydrophilic character of chitosan films. 

Swelling behavior 

Swelling behavior of chitosan films is presented in Figure 2. As expected, 

cross linking reaction decreased the swollen of films. However, this effect 

was inversely proportional to the degree of cross linking. lt can be 

attributed to the cross linking agent hydrophilic character. 

Swelling Behavior 
100 
90 
80 
70 

,-._ 
60&amp;lt;f 

~ 50 

"' 
40 
30 
20 
10 
o 

O% cross linked 30% cross linked 50% cross linked 
chitosan chitosan chitosan 

Samples 

Figure 2- Swelling behavior of samples. 

In vitro release 

Silver sulfadiazine is poorly water soluble (0.34 mg/1 00 ml) and after 

dissociation, releases silver as well as sulfadiazine ions. Thus, silver 

sulfadiazine release can be divided in two steps: sulfadiazine release and 

silver release. Because there is no interaction between sulfadiazine and 

chitosan, sulfadiazine release depends on the solubility of silver 

sulfadiazine in the dissolution medium. However, chitosan contains amino 

groups which are capable of binding silver and hence, silver release 

91 



depends also on the chemical interactions between silver ions and 

chitosan. Moreover, both releases depend on the mass transport 

resistance caused by chitosan tilms. 

According to Figure 3, ali samples displayed a burst release in the tirst 

days. This initial release is very important to tast contrai bacterial intection 

in wounds treatment. After this initial period, slow release ot sultadiazine 

was observed. 

Figure 4 well illustrated sultadiazine cumulative release. Samples 2, 5 and 

8, containing 5% silver sulfadiazine initial concentration, showed similar 

behavior and have released around 30% of theirs initial concentration after 

14 days, while samples 3, 6 and 9 (1 0% silve r sultadiazine initial 

concentration) have released more than 15%. 

According to these results and due to silver sulfadiazine low molecular 

weight, chitosan tilms mass transport resistance did not control 

sulfadiazine release, but silver sulfadiazine solubility did. Samples 3, 6 and 

9 that contained twice the silver sulfadiazine initial concentration of 

samples 2, 5 and 8 showed approximately half of cumulative silver 

sulfadiazine release observed for samples 2, 5 and 8. 

Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia co/i 

are the most common pathogens found in burns and skin wounds. Silver 

sulfadiazine minimal inhibition concentration (MIC) was found to be 32 

11g/ml for Escherichia co/i, 44.8 11g/ml for Pseudomonas aeruginosa and 

57.6 119/ml for Staphy/ococcus aureus. [1] Besides, minimal bactericida! 

concentration (MBC) was 40.2 11g/ml and 51.2 11g/ml for Escherichia co/i 

and Pseudomonas aeruginosa, respectively. For Staphylococcus aureus 

MBC was equal to MIC. 

Thus, samples 2, 5 and 8 released enough amount of silver sulfadiazine to 

inhibit these three pathogens just in the first day, while samples 3, 5 and 9 

only did not release enough silver sulfadiazine to inhibit Staphylococcus 

aureus. From the second day on, ali samples have kept minimum inhibitory 

concentration for ali three pathogens. Therefore, the presence of infection 

92 



as well as the ídentífícatíon of pathogen should be consídered before 

sample selectíon sínca mínímal sílver sulfadíazíne should ba released to 

avoíd silvar axcess and body absorptíon. 

Sulfadiazine Cumulative Release 

35 

30 :l 

J. 

5 

ft-
j 

-~ 
j 

~-·-·- - -- --- - - l 7!" --· 
; 

71V 
j 
i 

• 

7/V -sample2 -sample3 
f/ ..,.._sample5 ~sample6 

-9-sample 8 ~sample9 

25 

10 

o 
o 2 3 4 5 6 7 8 9 10 11 12 13 14 

Days 

Figure 3 - Sulfadíazína cumulativa relaase. 

Sulfadiazine cumulative release after 14 days 

35 

30 

25 

~ 20 
o 

~ 
r$- 15 

10 

5 

o 
2 3 5 6 8 9 

Samples 

Figure 4 - Sulfadíazína cumulativa raleasa aftar 14 days. 

93 



CONCLUSION 

Chitosan - Hexamethylene 1 ,6-Di (aminocarboxysulfonate) cross linking 

reaction was efficient and confirmed by FTIR and swelling analyses. Cross 

linked films swollen less than chitosan one and this effect was inversely 

proportional to cross linker concentration, due to the hydrophilic character 

of the cross linking agent. Moreover, according to contact angle analysis, 

cross linked films became more hydrophilic than chitosan film. Besides, the 

effect of cross linker concentration could not be evaluated because the 

water drop spread on both cross linked films. 

Silver sulfadiazine release was controlled by its solubility in the dissolution 

medium. Because of silver sulfadiazine low molecular weight, mass 

transport resistance did not govern the diffusion process. 

Samples with higher silver sulfadiazine initial concentration should be used 

to treat infected wounds, while the samples with lower one could be used 

to avoid wound infections. 

Additional experiments such as in vitro and in vivo wound healing were 

carried out with selected samples and will be published in a further paper. 

REFERENCES 

[1] N. Shanmugasundaram, J. Sundaraseelan, S. Uma, D. Selvaraj, Mary 

Babu. Design and delivery of silver sulfadiazine from alginate 

microspheres-impregnated collagen scaffold. 2005. 

[2] Tsipouras N, Rix CJ, Brady PH. Solubility of silver sulfadiazine in 

physiological media relevance to treatment of thermal burns with silver 

sulfadiazine cream. Clin Chem 1995; 41 :87-91. 

[3] K. Kurita, Chemistry and Application of chitin and chitosan. Polymer 

Degradation and. Stabifity 59 (1998) 117-120. 

[4] J. Berger, Structure and lnteractions in covalently and ionically cross 

linked chitosan hydrogels for biomedical applications. European Journal of 

Pharmaceutics and Biopharmaceutics 57 (2004) 19-34. 

94 



[5] C. Hoemann, Tissue engineering of cartilage using an injectable and 

adhesive chitosan-based cell-delivery vehicle. Osteoarthritis Cartilage 13 

(2005) 318-329. 

[6] E. Denkbas, Norfloxacin-loaded Chitosan Sponges as Wound Dressing 

Material. Journal of Biomaterials Application 18 (2004) 291-303. 

[7] H. Ueno, Topical formulations and wound healing applications of 

chitosan. Advanced Drug Delivery Review 52 (2001) 105-115. 

[8] Sheng Lin-Gibson, Howard J. Walls, Scott B. Kennedy, Eric R. Welsh. 

Reaction kinetics and gel properties of blocked diisocyanate cross linked 

chitosan hydrogels. Carbohydrate Po/ymers 54(2003) 193-199. 

[9] Eric R. Welsh, Caroline L. Schauer, Syed B. Qadri and Ronald R. Price. 

Chitosan cross-linking with a water-soluble, blocked diisocyanate. 1.Solid 

state. Biomacromolecules 3 (2002) 1370-1374. 

95 



4.8 In Vitro Wound Healing Responses to Drug Loaded Cross Linked 
Chitosan Films 

Avaliação in vitro da cicatrização de feridas tratadas com filmes 

reticulados de quitosana carregados com fármacos 

Campos, M.G.NY, Rawls, R.H. 1 , Mei, L.H.I. 2 and Satsangi, N. 1 

' Departamento de Odontologia Restaurativa. Divisão de Biomateriais Division, Escola de 

Odontologia, Centro de Saúde da Universidade do Texas em San Antonio, TX, EUA 

2 Departamento de Tecnologia de Polímeros, Faculdade de Engenharia Química, 

Universidade Estadual de Campinas, SP, Brasil 

RESUMO: Atualmente, o uso de cobaias em experimentos de pesquisa 

tem sido amplamente questionado pelas Instituições e Organizações 

protetoras de animais. Por outro lado, testes preliminares e validação 

científica da hipótese de pesquisa são requeridos antes de um teste in 

vivo ser aprovado. Devido às numerosas etapas a serem completadas até 

se conseguir a aprovação de um estudo in vivo, este procedimento pode 

levar muito tempo. Por todas estas razões, o desenvolvimento de um 

teste in vitro capaz de substituir a pesquisa em animais seria muito 

interessante. Com esse objetivo, este trabalho dedicou-se ao 

desenvolvimento de um novo modelo de ferida in vitro para a avaliação do 

potencial cicatrizante de filmes de quitosana carregados de antibióticos. 

MG-63, uma linhagem de células derivada de um osteosarcoma, foi usada 

no modelo in vitro, enquanto que os filmes de quitosana foram carregados 

com gentamicina e sulfadiazina de prata, um antibiótico e um agente 

antibacteriano, respectivamente. 

PALAVRAS-CHAVE: quitosana, antibiótico, cicatrização de ferida, cultivo 

celular, in vitro. 

96 



In vitro wound healing responses to drug loaded cross linked 

chitosan films 

Campos, M.G.NY, Rawls, R.H.\ Mei, L.H.I. 2 and Satsangi, N. 1 

1 Department of Restorative Dentistry, Biomaterials Division, Dental 

School, University of Texas Health Science Center at San Antonio, TX, 

USA 

2 Department of Polymer Technology, Faculty of Chemical Engineering, 

State University of Campinas, SP, Brazil 

ABSTRACT: Currently, animais use in research experiments has been 

widely questioned by Animal Protect lnstitutions and Organizations. 

Moreover, preliminary tests and scientific validation of research hypothesis 

are required before in vivo tests be approved. Due to the numerous steps 

to be accomplished before in vivo study approval, this procedure could 

take a long time. For ali these reasons, the development of an in vitro test 

that could replace animal research would be very interesting. Therefore, 

the aim of this work was the development of a novel in vitro wound model 

for evaluation of the healing potential of drug loaded chitosan films. MG-63, 

a cell line derived from an osteosarcoma, was used in the in vitro model, 

while chitosan films were loaded with gentamicin and silver sulfadiazine, 

an antibiotic and an antibacterial agent, respectively. 

KEYWORDS: chitosan, antibiotic, wound healing, cell culture, in vitro. 

INTRODUCTION 

Animal testing or animal research refers to the use of animais in research 

experiments. Worldwide, about 100 million animais [1] are used annually 

and either killed during the experiments or subsequently euthanized. 

Animal research is mainly carried out inside universities, medicai schools 

and pharmaceutical companies, although some commercial facilities 

provide animal-testing services to industry. [2] 

97 



Groups that supports animal research affirm that it has played a vital role in 

every major medicai advance and that many major developments, such as 

penicillin (mice), organ transplant (dogs), and poliomyelitis vaccine (mice, 

monkeys) involved animal research. [3] However, the topic is controversial. 

Opponent groups argue that animal testing is unnecessary, poor scientific 

practice, poorly regulated, that the costs outweigh the benefits, or that 

animais have an intrinsic right not to be used for experimentation. 

Nevertheless, most scientists and governments agree that animal testing 

should cause as little suffering to animais as possible, and that animal 

tests should only be performed where necessary, respecting the three R's 

principie: Reducing, Replacement and Refinement. In this context, the 

development of in vitro tests that could replace preliminary animais testing 

is an interesting, current and crucial research field. 

Chitosan is a biopolymer derived from chitin, the second most abundant 

polysaccharide found in nature. Due to its interesting biological properties 

such as: biocompatibility, biodegradability, antibacterial activity and bio-

adhesion, it has been widely studied and applied as a biomaterial in the 

biomedical area.[4 and 5] Biomedical applications of chitosan involve 

implants, drug delivery matrix, scaffolds for tissue engineering, skin 

substitutas and wound dressings [6, 7 and 8]. In this present work, drug 

loaded chitosan films for wound dressing were prepared and their wound 

healing potential was in vitro evaluated. 

Gentamicin, an amino-glycoside antibiotic, and silver sulfadiazine, a 

standard antibacterial agent for burns treatment, were used to prepare the 

drug loaded chitosan films. They are topically used for treatment of skin 

infections and burn wounds for a long time. Gentamicin is one of the most 

consumed antibiotics in the world. lts high consumption is due to its low 

cost, wide antibacterial spectrum of action, low rate of primarily resistant 

pathogens, low allergy rate, as well as good thermo-stability and water 

solubility. [9] 

98 



Silver sulfadiazine possesses a wide spectrum of activity against Gram 

positive and negative bacteria and fungus. [1 O] Besides, it is effective even 

at low concentrations due to the presence of silver íons that kill bacteria 

and do not cause pathogen resistance. 

For the in vitro model, human MG-63 cells, a cell line derived from an 

osteosarcoma, was cultured. Wounds were created and the healing 

potential of drug loaded chitosan films were qualitatively evaluated by the 

wound filling rate. 

MATERIALS ANO METHODS 

Materiais 

High molecular weight chitosan (&gt;75% deacetylated), hexamethylene 

diisocyanate and silver sulfadiazine were purchased from Aldrich. 

Gentamicin sulfate salt was purchased from Sigma and sodium bisulfite 

Reagent Plus®, from Sigma-Aidrich. MG-63 cell line was gently supplied 

by Dr. Cohen. 

Synthesis of cross linking agent 

In a 100 ml round-bottom flask containing a magnetic stir bar, 6.73 g (40 

mmol) of HMDI was added to 8.36 g Na2S20s (44 mmol) dissolved in 15.53 

ml H20 and was stirred for 20h at room temperature. The product was 

precipitated in acetone and dried in vacuum. lnsoluble polymeric 

byproducts were removed by dissolving the product in water (30 ml) 

followed by filtration. Product was isolated from the filtrate by precipitation 

in acetone and dried in vacuum, resulting in a white powder. (11] 

Preparation of chitosan film 

1.5g of chitosan was dissolved in 100 ml of 1.0% acetic acid solution. After 

total dissolution, solution was cast in the molds and dried at room 

temperature. 

99 



Cross linking reaction 

In a 250 ml flask, 0.8g of hexamethylene 1 ,6-di(aminocarboxysulfonate) 

was added to 100 ml of 1.5% chitosan solution and heated up to 40 "C 

under stirring for 24 h. 

Preparation of chitosan cross linked film 

The solution above described was cast in the molds and dried at room 

temperature in order to prepare the chitosan cross linked film. 

Preparation of gentamicin loaded film 

After cross linking reaction, 1% gentamicin sulfate was added and 

homogenized for 24 h. Then, the resulted solution was cast in the molds 

and dried at room temperature. Dried samples were then neutralized in 

Ethanol 70% for 30 minutes and sterilized in UV light. 

Preparation of si/ver sulfadiazine loaded film 

The same procedure was used to prepare silver sulfadiazine loaded films. 

However, 5% silver sulfadiazine was used instead of 1% gentamicin 

sulfate. 

Ce/1 cu/ture 

MG-63 cells were seeded in six-well tissue culture plates (Corning Co, 

Houston, TX). The seeded cells were incubated in a-MEM (Minimum 

Essential Media Alpha Medium) with 5% fetal bovine serum (FBS) and 

humidity atmosphere of 5% C02 and 95% air at 37° C. After cells reached 

confluence, wounds were created across the surface of each well (Figure 

1) and the media were changed. The wounds were then examined 

microscopically to ensure that cellular and extra-cellular materiais were 

removed from the wound sites. 

100 



Figure 1 - In vitro wounds. Figure 2- In vitro wound 
healing atO day. 

At this moment, chitosan films were placed in the wells and in each plate, 

the positive control was a well with no film. In order to evaluate chitosan 

effect on wound filling rate, a chitosan film was incubated. Besides, a cross 

linked chitosan film was also incubated to evaluate cross linking agent 

effect on in vitro wound healing. Gentamicin and silver sulfadiazine effects 

were evaluated by incubation of drug loaded cross linked chitosan films. 

Samples were identified according to Table 1 and the experiment was 

carried out on duplicates. At every two days, culture media were replaced 

in order to provide essentials nutrients for cellular growth. 

Table 1 - Samples identification. 

Samole Content 
A No film !Positive controTl 
B Chitosan film 
c Chitosan cross linked film 
D Gentamicin loaded chitosan cross linked film 

E 
Silver sulfadiazine loaded chitosan cross linked 
film 

Determination of wound filling rate 

Wound filling rate was qualitatively measured after O, 7, 14 and 21 days of 

incubation by using a microscope with photography apparatus. 

After each desired period, films were removed from the wells and kept in 

formol for 24 hours for further investigation. Then, the cells were stained 

with 20 ml of T-blue for 2 minutes at 37" C. After staining, ali media were 

removed and cells were washed with 1 ml of 0.1 M phosphate buffer 

solution (PBS) pH 7.4. Then, PBS was removed and 1 ml of formol was 

101 



added. Cells were kept at 4"C for 24 hours and, after this procedure, 

formal was replaced for ethanol 70%. At this moment, cells were ready to 

be photographed and the wound filling rate was qualitatively determined by 

the amount of cells that grown in each wound site. 

RESULTS 

Figure 2 illustrates the wound at O day. As expected, cells were stained, 

while the wound site was not. In vitro wound healing results for 7, 14 and 

21 days are presented in Figure 3. According to Figure 3, samples D and E 

showed inferior wound filling rate when compared to positive contrai 

(sample A) in the first week. However, this effect was not observed for 

sample D in the next week. At 21 days, excepted for sample E, wound 

sites were almost totally filled by cells. 

Lee et a/ [12) reported the cytotoxic effect o f silve r sulfadiazine on HaCa T 

cells and delayed epithelialization in animal model. Besides, a marked 

inhibition of 3T3 fibroblasts growth, caused by 1% silver sulfadiazine 

cream, was observed by Mi et ai [13). However, according to authors, this 

inhibition was significantly reduced by the use of a silver sulfadiazine 

incorporated asymmetric chitosan membrane. 

Gentamicin ototoxicity and neuphrotoxicity have been extensively studied. 

[14 and 15) Nevertheless, these deleterious effects seem to be dosing 

dependent and have not been well established yet. Lin et ai [16) reported 

that application of 2% gentamicin eye drops in porcine cornea disturbed 

the corneal epithelial healing rate significantly. Bertolaso et ai [17) reported 

the biochemical mechanism underlying gentamicin cytotoxicity in OC-k3 

cells. However, cytotoxic effect of gentamicin on fibroblast growth is not 

well discussed. According to figure 3, gentamicin deleterious effect only is 

significant in the first week of in vitro wound healing. Probably, this is an 

adaptation period to the cells and after that, wound filling rate is recovered. 

Past 21 days, sample D wound filling is almost equivalent to sample A 

(positive contrai). 

102 



7DAYS 14DAYS 21 DAYS 

A 

B 

c 

D 

E 

Figure 3- In vitro wound healing results. 

Lee et ai [i 2] reported the cytotoxic effect of silver sulfadiazine on HaCaT 

cells and delayed epithelialization in animal model. Besides, a marked 

inhibition of 3T3 fibroblasts growth, caused by i% silver sulfadiazine 

cream, was observed by Mi et ai [i 3]. However, according to authors, this 

103 



inhibition was significantly reduced by the use of a silver sulfadiazine 

incorporated asymmetric chitosan membrane. 

Gentamicin ototoxicity and neuphrotoxicity have been extensively studied. 

[14 and 15] Nevertheless, these deleterious effects seem to be dosing 

dependent and have not been well established yet. Lin et a! [16] reported 

that application of 2% gentamicin eye drops in porcine cornea disturbed 

the corneal epithelial healing rate significantly. Bertolaso et a! [17] reported 

the biochemical mechanism underlying gentamicin cytotoxicity in OC-k3 

cells. However, cytotoxic effect of gentamicin on fibroblast growth is not 

well discussed. According to figure 3, gentamicin deleterious effect only is 

significant in the first week of in vitro wound healing. Probably, this is an 

adaptation period to the cells and after that, wound filling rate is recovered. 

Past 21 days, sample O wound filling is almost equivalent to sample A 

(positive control). 

Chitosan and cross linked chitosan films (samples B and C, respectively) 

did not show cytotoxicity, but stimulated cells growth. Ueno et a! [18] 

reported that chitosan stimulated migration and proliferation of fibroblast 

and also collagen production in dogs' wound healing. Moreover, wound 

healing experiments using mouse model have shown that the application 

of chitosan hydrogel onto an open wound induced significant wound 

contraction and accelerated wound healing. [19] 

CONCLUSION 

In vitro wound healing model results have shown to be comparable to 

those obtained in previous animal studies. Therefore, the presented in vitro 

wound healing model could replace preliminary animal testing, 

collaborating to the three R principies: reduction, replacement and 

refinement. 

As expected, chitosan films enhanced cells growth. In addition, cross 

linked chitosan films was not cytotoxic for MG-63 cells and thus, 

hexamethylene 1 ,6-di(aminocarboxysulfonate) can be considered a safety 

cross linking agent. 

104 



Wound healing deleterious effects of drug loaded chitosan films on in vítro 

wound healing were more pronounced for silver sulfadiazine that disturbed 

wound filling during ali 21 days. Cells growth was initially delayed by 

gentamicin, however, after this adaptation period, cells started to grow fast. 

In this context, the use of drugs in wound treatments should be carefully 

evaluated since it could delay wound healing, instead of accelerate it. 

REFERENCES 

[1) "The Ethics of research involving animais", Nuffield Council on 

Bioethics, p. 45. 

[2) Use of Laboratory Animais in Biomedical and Behavioral Research", 

lnstitute for Laboratory Animal Research, The National Academies Press, 

1988. 

[3) "FBR's Position on Animal Research", Foundation for Biomedical 

Research. 

[4) K. Kurita. Chemistry and application of chitin and chitosan. Polymer 

Degradatíon and. Stabílíty 59 (1998) 117-120. 

[5) J. Berger, Structure and lnteractions in covalently and ionically cross 

linked chitosan hydrogels for biomedical applications. European Journal of 

Pharmaceutics and Biopharmaceutícs 57 (2004) 19-34. 

[6) Hoemann, C.D., Sun, J., Legare, A., McKee, M.D. and Buschmann, 

M.D. (2005). Tissue engineering of cartilage using an injectable and 

adhesive chitosan-based cell-delivery vehicle, Osteoarthritis Cartilage, 13: 

318-329. 

[7] Denkbas, E.B., Ozturk, E.,Ozdemir, N.,Kececi, K. and Agalar, C. 

(2004).Norfloxacin-loaded chitosan sponges as wound dressing material, 

Journal of Biomaterials Applications, 18(4):291-303. 

[8] Ueno, H., Mo ri, T. and Fujinaga, T. (2001 ). Topical formulations and 

wound healing applications of chitosan, Advanced Drug Delivery Review, 

52(2): 105-115. 

105 



[9] M.R. Virto, P. Frutos, Susana Torrado and G. Frutos. Gentamicin 

release from modified acrylic bane cements with lactose and 

hydroxylpropylmethylcelullose. Biomaterials 24 (2003) 79-87. 

[1 O] N. Shanmugasundaram, J. Sundaraseelan, S. Uma, D. Selvaraj, Mary 

Babu. Design and delivery of silver sulfadiazine from alginate 

microspheres-impregnated collagen scaffold. 2005. 

[11] Sheng Lin-Gibson, Howard J. Walls, Scott B. Kennedy, Eric R. Welsh. 

Reaction kinetics and gel properties of blocked diisocyanate cross linked 

chitosan hydrogels. Carbohydrate Polymers 54(2003) 193-199. 

[12] Ae-Ri Cho Lee, Hyunju Leem, Jaegwan Lee, Kyung Chan Park. 

Reversal of silver sulfadiazine-impaired wound healing by epidermal 

growth factor. Biomaterials 26 (2005) 4670-4676. 

[13] Fwu-Long Mi, Yu-bey Wu, Shin-Shin Shyu, An-chong Chao, Yuin-Yih 

Lai, Chia-Ching Su. Asymmetric chitosan membranes prepared by dry/wet 

phase separation: a new type of wound dressing for controlled antibacterial 

release. Journal of Membrane Science 212 (2003) 237-254. 

[14] Aminoglycoside-lnduced Hearing Loss in Humans. ROBERT E. 

BRUMMETT ANO KA YE E. FOX. ANTIMICROBIAL AGENTS ANO 

CHEMOTHERAPY, June 1989, p. 797-800 

[15] J. Marais and J. A.Rutka. Ototoxicity and topical ear drops. Clin. 

Otolaryngol. 1998, 23, 360-367. 

[16] Gentamicin-lnduced Cytotoxicity lnvolves Protein Kinase C Activation, 

Glutathione Extrusion and Malondialdehyde Production in an lmmortalized 

Cell Line from lhe Organ of Corti. Lucia Bertolasoa, Debora Bindinib, 

Maurizio Previatia, Daniela Falgioneb, lrene Lanzonib, Alina Parmeggianib, 

Cristina Vitalia, Elisa Corbacellab, Silvano Capitania,b, Alessandro 

Martinib. Audiology &amp;amp; Neurotology, V oi. 8, No. 1, 2003. 

106 



[1 ?]_Effect of Fortified Antibiotic Solutions on Corneal Epithelial Wound 

Healing. 

Basic lnvestigation. Cornea. 1 9(2):204-206, March 2000.Lin, Chang-Ping 

M.D.; Boehnke, Matthias M.D. 

[1 8] Ueno, H., Yarnada, H., Tanaka, 1., Kaba N., Matsura M., Okumura M., 

Kadosawa, T., Fujinaga, T. Accelerating effects of chitosan for healing at 

early phase of experimental open wounds in dogs. Biomaterials 1999; 20: 

1407-1414. 

[1 9] Masayuki lshihara, Kuniaki Nakanishi, Katsuaki Ono, Masato Sato, 

Makoto Kikuchi, Yoshio Saito, Hirofurni Yura, Takemi Matsui, Hidemi 

Hattori, Maki Uenoyama, Akira Kurita. Photocrosslinkable chitosan as a 

dressing for wound occlusion and accelerator in healing process. 

Biomaterials 23 (2002) 833-840. 

107 



6. CONCLUSÕES 

• As soluções de quitosana apresentaram atividade antibacteriana 

contra a bactéria Escherichia co/i, e a inibição do crescimento foi 

inversamente proporcional à concentração de quitosana; 

• A solução de plastificante (d-sorbitol), bem como a solução 

solvente (ácido acético 1.0%) também apresentaram atividade 

antibacteriana contra a bactéria E. co/i; 

• A membrana de quitosana (CA) apresentou a menor 

permeabilidade ao vapor d'água devido à sua alta cristalinidade; 

• Apesar de apresentar propriedades mecânicas aceitáveis, CA 

apresentou citotoxicidade direta às células Vero devido à presença 

de ácido acético residual; 

• A neutralização foi uma etapa muito importante na preparação das 

membranas de quitosana, pois: 

1- Neutralizou o ácido acético residual que é diretamente citotóxico; 

2- Diminuiu o grau de hidratação das membranas, evitando a formação 

de gel após contato com a água; 

3- Aumentou a permeabilidade ao vapor de água; 

• A membrana neutralizada (CN) apresentou o menor grau de 

hidratação e permeabilidade ao vapor d'água intermediária quando 

comparada às membranas plastificada (CP) e não-neutralizada 

(CA); 

• O D-sorbitol é um plastificante seguro para as células, porém, 

devido ao seu caráter altamente higroscópico, o grau de hidratação 

das membranas de quitosana aumentou muito com a adição deste 

plastificante; 

• A adição de plastificante também aumentou a permeabilidade ao 

vapor de água e a flexibilidade das membranas de quitosana; 

108 



• As membranas de quitosana CN e CP mostraram-se satisfatórias 

para uso como recobrimentos de feridas; entretanto, as mesmas 

devem ser reticuladas a fim de serem utilizadas como sistemas de 

liberação controlada de fármacos; 

• A reação de reticulação da quitosana com o hexametileno 1 ,6-di-

(aminocarboxisulfonato) foi bem sucedida. Os graus de reticulação 

foram 30 e 50%; 

• O hexametileno 1 ,6-di-(aminocarboxisulfonato) mostrou-se um 

excelente agente reticulante. Como o material reticulado não ficou 

quebradiço, a adição de plastificante não foi necessária; 

• O grau de hidratação das membranas de quitosana reticuladas foi 

inversamente proporcional à concentração de agente reticulante, 

devido à elevada hidrofilicidade do mesmo; 

• A reticulação aumentou o caráter higroscópico das membranas de 

quitosana, e consequentemente, a biocompatilidade do material; 

• De acordo com os testes , as membranas reticuladas de quitosana 

mostraram-se eficientes na liberação controlada de gentamicina e 

sulfadiazina de prata; 

• O modelo de cicatrização de feridas in vitro utilizando a linhagem 

celular MG - 63, mostrou-se um excelente método para se estudar 

os efeitos dos agentes antimicrobianos no processo de 

cicatrização; 

• As membranas de quitosana, reticuladas ou não, favoreceram o 

crescimento in vitro das células MG -63 quando adicionadas ao 

meio de cultivo celular; 

• A membrana de quitosana 30% reticulada, carregada com 1% de 

gentamicina, inibiu inicialmente o crescimento in vitro das células 

MG- 63; 

109 



• A membrana de quitosana 30% reticulada, carregada com 5% de 

sulfadiazina de prata, inibiu parcialmente o crescimento in vitro das 

células MG - 63; 

• A utilização ou não de antibióticos ou agentes antimicrobianos 

deve ser seriamente considerada durante o tratamento de feridas, 

uma vez que a utilização dos mesmos pode comprometer o 

processo de cicatrização. 

110 



7. SUGESTÕES PARA TRABALHOS FUTUROS 

• Estudar a liberação controlada de agentes antiinflamatórios e 

outros tipos de medicamentos, utilizando os mesmos sistemas de 

liberação à base de quitosana reticulada; 

• Avaliar as propriedades mecânicas, térmicas e de permeabilidade 

dos sistemas de liberação obtidos; 

• Desenvolver sistemas de liberação controlada de fármacos para 

recuperação de cartilagem de eqüinos. 

111 



8. REFERÊNCIAS 

• ARVANITOYANNIS, I.S., NAKAYAMA, A. ANO AIBA, S. Chitosan 

and gelatin based edible films: state diagrams, mechanical and 

permeation properties. Carbohydrate Polymer, v.37, p.371-382, 

1998. 

• BLACK, J.M., MATASSARIN-JACOBS, E.M., LUKMAN, S. 

Enfermagem médico-cirúrgica: uma abordagem Psicofisiológica. 4ª 

ed. Rio de Janeiro (RJ): Guanabara 1996; 

• CHO LEE, A. R. Effects of Silver Sulfadiazine on the skin cell 

proliferation and wound healing process in Hairless mouse 2nd 

degree burn model. Journal ot Korean Pharmaceutical Science, 

v.32, p.113-117, 2002. 

• Cidade Sustentável, 2004 

Disponível em: 

http://www.gabeira.com.br/cidadesustentavel/atitudes/mostra.atit.as 

p?id=15 

Acesso em: 10/02/2005. 

• CRUZ, MARIA CLARA PINTO. Influência do Poli (Etileno Glicol) 

(PEG) no Processo de Microencapsulação da Oxitetraciclina no 

Sistema Alginato/ Quitosana: Modelamento "IN VITRO" da 

Liberação Oral. Campinas: Faculdade de Engenharia Química, 

Universidade Estadual de Campinas, 2004. Tese (Doutorado). 

• DENKBAS, E. B., ÓZTÜRK, E., ÓZDEMIR, N., KEÇECI, K. 

Norfloxacin-loaded chitosan sponges as wound dressing material. 

Journal of Biomaterials App/ications, v.18, p.291-303, 2004. 

• FERRAZ, E.M., FERRAZ, A.A.B., BACELAR, T.S., 

D'ALBUQUERQUE, H.S.D., VASCONCELOS, M.D.M.M., LEÃO, 

C.S. Controle de infecção em cirurgia geral -resultados de um 

estudo prospectivo de 23 anos e 42.274 cirurgias. Revista do 

Colégio Brasileiro de Cirurgiões, v.28, p.17-26, 2001. 

112 



• lnventaBrasiiNet, 2002 

Detector de bactérias, março/2002 

Disponível em:http://inventabrasilnet.t5.com.br/infecmw.htm 

Acesso em: 11/02/05. 

• KLUYTMANS, J. Surgical infections including burns. In: Wenzel PR, 

editor. Prevention and contrai of nosocomial infection. Baltimore: 

Williams &amp;amp; Wilkins; 1997,841-65. 

• KURITA, K. Chemistry and Application of chitin and chitosan. 

Po/ymer App/ication and Stability, v. 59, p.117 -120, 1998. 

• LAVA, 2005 

Disponível 

em:http://www.lava.med.br/vascular _geral/gazeta1211 OO.htm 

Acesso em: 10/02/2005. 

• LIN-GIBSON, S., WALLS, J. H., KENNEDY, S. B., WELSH, E. R. 

Reaction kinetics and gel properties of blocked diisocyanate cross 

linked chitosan hydrogels. Carbohydrate Polymers, v.54, p.193-199, 

2003. 

• LOKE, W-K., LAU, S-K., YONG, L. L., KHOR, E., SUM, C. K. 

Wound Dressing with Sustained Anti-Microbial Capability. Journal 

ot biomedica/ materiais research, v.53, p.8-17, 2000. 

• MAEDA, Y, KIMURA, Y. Antitumor Effects of Various Low-

Molecular-Weight Chitosans Are Due to lncreased Natural Killer 

Activity of Intestinal lntraepithelial Lymphocytes in Sarcoma 180 -

Bearing Mice. Journal of Nutrition, v.134, p.945-950, 2004. 

• MANGALA, E, SURESH KUMAN, T, BASKAR, S AND 

PANDURANGA RAO, K. Development of chitosan/poly(vinyl 

alcohol) blend membrane as burn dressing. Trends Biomaterials in 

Artificial Organs, v.17, n.1, p.34-40, 2003. 

113 



• Ml, F-L., WU, Y-8., SHYU, S-S., CHAO, A-C., LAI, J-Y., SU, C-C. 

Asymmetric chitosan membranes prepared by dry/wet phase 

separation: a new type of wound dressing for controlled antibacterial 

release. Journai o f Membrana Science, v.212, p.237 -254, 2003. 

• NARAHARISETTI, P. K., LEE, H. C. G .. , FU, Y-C, LEE, D-J, 

WANG, C-H. In Vitro and In Vivo release of Gentamicin from 

8iodegradable Discs. Journai of biomedicai materiais research. Part 

8, Appiied biomateriais, p.329-337, 2006 

• OZKAYNAK, M. U., ATALAY-ORAL, C., TANTEKIN-ERSOLMAZ, S. 

8., GÜNER, F. S. Polyurethane Films for Wound Dressing 

Applications. Macromoiecuiar Symposia, v.228, p.177, 2004. 

• Polymar, 2004 

Disponível em: http:llwww.polymar.eom.br/empresalempresa.php 

Acesso em: 10/02/2005. 

• Portal Saúde.Gov, 2005 

Saúde cria Redes Estaduais de Assistência a Queimados 

Data: 2211112000 

Disponível em: 

http :1 I portal web02. saude. gov. b r/saudei aplicacoes/noticiaslnoticias 

Acesso em: 10102/2005. 

• PURNA, S.K., 8A8U, M. Collagen based dressing: a review. Burns, 

v.26, p.54-62, 2000. 

• SHANMUGASUNDARAM, N., SUNDARASEELAN, J., UMA, S., 

SELVARAJ, D., MARY 8A8U. Design and delivery of silver 

sulfadiazine from alginate microspheres-impregnated collagen 

scaffold, Journai of biomedicai materiais research. Part B, Appiied 

biomateriais, v.77, n.2, p.378-88, 2006. 

• SILVA, R.M., SILVA, G.A., COUTINHO, O.P., MANO, J.F., REIS, 

R.L.. Preparation and characterization in simulated body conditions 

114 



ot glutaraldehyde crosslinked chitosan membranes. Journal of 

Materiais Science: Materiais in Medicine, v.15, p.11 05-1112, 2004. 

• SKUNDRIC, P., MEDOVIC, A., KOSTIC, M .. Fibrous systems with 

programmed biological activity and their application in medicai 

practice. AUTEX Research Journal, v.2, p.78, 2002. 

• SUYATMA, NE, TIGHZERT, L and COPINET, A. Effects of 

Hydrophilic Plasticizers on Mechanical, Thermal, and Surface 

Properties of Chitosan Films. Journal of agricultura/ and food 

chemistry, v.53, p.3950, 2005. 

• SYNOWIECKI, J., AL-KHATEEB, N. A. Production, Properties and 

some new applications of chitin and its derivatives. Criticai Reviews 

in Food Science and Nutrition, v.43, n.2, p.145-171, 2003 

• Universia, 2004 

Disponível em: http://www.universiabrasil.net/html!noticia_iehib.html 

Acesso em: 08/02/2005. 

• VIRTO, M.R., FRUTOS, P., TORRADO, S., FRUTOS, G. 

Gentamicin release from modified acrylic bane cements with lactose 

and hydroxypropylmethylcellulose. Biomaterials, v.24, p.79-87, 2003 

• WELSH, E. R., SCHAUER, C. L., QADRI S. B. AND PRICE, R. R. 

Chitosan cross-linking with a water-soluble, blocked diisocyanate. 

1.Solid state. Biomacromolecules, v.3, p.1370-1374, 2002. 

• WENLING, C., CHENG, M., AO, 0., GONG, Y., ZHAO, N., ZHANG, 

X. Physical, mechanical and degradation properties, and schwann 

cell attinity ot cross-linked chitosan films. Journal of Biomaterials 

Science, v.16 (6), p. 791-807, 2005. 

• YU, S-H., Ml, F-L., WU, Y-B., PENG, C-K., SHYU, S-S. Antibacterial 

Activity of Chitosan-Aiginate Sponges lncorporating Silver 

Sulfadiazine: Effect of Ladder-Loop Transition of lnterpolyeletrolyte 

115 



Complex and lonic Crosslinking on lhe Antibiotic Release. Journal 

of App!ied Polymer Science, v.98, p.538-549, 2005. 

• ZHANG, X., WYSS, U. P., PICHORA, D., GOOSEN, M. F. A. 

Biodegradable Controlled Antibiotic Release Devices for 

Osteomyelitis: Optimization of Release Properties. The Journal of 

pharmacy and pharmacology, v.46, p.718-724, 1994. 

• ZHANG, Y., ZAHANG, M. Calcium phosphate/chitosan composite 

scaffolds for controlled in vitro antibiotic drug release. Journal of 

biomedical materiais research, p.378-386, 2002. 

116 



9. APÊNDICES 

9.1 TESTE IN VIVO 

Como parte complementar ao presente estudo, foi feito um teste prel iminar 

qualitativo in vivo. O animal indicado e utilizado para tal teste foi o rato, 

devido ao seu tamanho/porte adequado e ao curto período de cicatrização 

destes animais. O teste in vivo foi conduzido da segui nte forma: 

1- Foram selecionados 1 O animais adultos, sadios, de sexo aleatório, 

pesando cerca de 500 g cada; 

2- Os animais foram anestesiados e depilados na parte dorsal; 

3- Oito feridas foram feitas no dorso de cada animal com o auxílio de um 

aplicador de cola quente, com a finalidade de simular uma queimadura; 

Figura 8- Aplicação da cola quente. 

4- Após 24 horas da aplicação da cola quente, os animais foram 

novamente anestesiados para a remoção do tecido morto e aplicação dos 

seguintes tratamentos: A- sem tratamento (controle); B - membrana 

de quitosana; C - membrana de quitosana 30% reticulada carregada 

com gentamicina a 1% e D- membrana de quitosana 30% reticulada 

e carregada com 1% de sulfadiazina de prata. 

11 7 

UNICAMI' 
OI R! IOF( A C ti Nl RAL 

Cts:\R LATTES 

0 ESEN VOL'v!MESTO OE COLCÇÁú 



Figura 9 - Aplicação dos tratamentos nas feridas. 

5- Depois de aplicados os tratamentos, foi passada bandagem para 

garantir que os tratamentos não fossem removidos pelos animais. Os 

animais foram então acondicionados em gaiolas individuais, com regime 

de 12 horas de luz/dia e alimentados normalmente; 

6- Após 7 dias, as bandagens foram retiradas e a cicatrização das feridas 

foi avaliada de acordo com os tratamentos aplicados. 

Figura 1 O - Cicatrização das feridas após 7 dias. 

118 



Os sinais de cicatrização observados para os tratamentos à base de 

quitosana foram: diminuição do raio da ferida e presença de pêlos. Em 

todas as situações, as feridas tratadas evoluíram melhor que a ferida 

controle. Entretanto, não foi possível observar diferença significativa entre 

os tratamentos B, C e D. 

O ensaio in vivo foi feito na University of Texas Health Science Center, 

respeitando os protocolos internacionais e as normas para a realização de 

testes com animais. 

2.6 CURVAS DE DSC 

Estão apresentadas a seguir, as curvas de DSC das membranas de 

quitosana (CA), quitosana neutralizada (CN) e quitosana-D-sorbitol (CP). 

:,,,~,. 

'''"' ,, 

CA 

Figura 11 - Curva de DSC para a membrana de quitosana. 

119 



"""'""' 
'"' ''"""'"'" •,u,, , "'" 4" 

;; 

CN 

·~· 

Figura 12- Curva de DSC para a membrana de quitosana neutralizada. 

g 
;;_ 
~ 

1 

·,~·o;•" 

'" '· ,,,.,, '"' 
"'&lt;""' ~~-~' 

O&amp;amp;:: '·'""'"'' '· •·no~ irM, "' &gt; 

CP 

- ---~-~--~-- ··~~__,-.. , 
',"',;: "''~' 

Figura 13- Curva de DSC para a membrana de quitosana plastificada. 

120 




</field>
	</doc>
</add>